2020


  1. Gluz O, Kolberg-Liedtke C, Prat A, Christgen M, Gebauer D, Kates R, Pare L, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Kuemmel S, Wuerstlein R, Pelz E, Nitz U, Kreipe HH, Harbeck N (2020). Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial. Int J Cancer, 146(1), 262-271.
     
  2. Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, Wappenschmidt B, Hubbel V, Maringa M, Reichstein-Gnielinski S, Hahnen E, Bartram CR, Dikow N, Schott S, Speiser D, Horn D, Fallenberg EM, Kiechle M, Quante AS, Vesper AS, Fehm T, Mundhenke C, Arnold N, Leinert E, Just W, Siebers-Renelt U, Weigel S, Gehrig A, Wockel A, Schlegelberger B, Pertschy S, Kast K, Wimberger P, Briest S, Loeffler M, Bick U, Schmutzler RK (2020). Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer, 146(4), 999-1009.
     
  3. Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, Wappenschmidt B, Hubbel V, Maringa M, Reichstein-Gnielinski S, Hahnen E, Bartram CR, Dikow N, Schott S, Speiser D, Horn D, Fallenberg EM, Kiechle M, Quante AS, Vesper AS, Fehm T, Mundhenke C, Arnold N, Leinert E, Just W, Siebers-Renelt U, Weigel S, Gehrig A, Wockel A, Schlegelberger B, Pertschy S, Kast K, Wimberger P, Briest S, Loeffler M, Bick U, Schmutzler RK (2020). Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer, 146(4), 999-1009.
     
  4. Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, Wappenschmidt B, Hubbel V, Maringa M, Reichstein-Gnielinski S, Hahnen E, Bartram CR, Dikow N, Schott S, Speiser D, Horn D, Fallenberg EM, Kiechle M, Quante AS, Vesper AS, Fehm T, Mundhenke C, Arnold N, Leinert E, Just W, Siebers-Renelt U, Weigel S, Gehrig A, Wockel A, Schlegelberger B, Pertschy S, Kast K, Wimberger P, Briest S, Loeffler M, Bick U, Schmutzler RK (2020). Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer, 146(4), 999-1009.
     
  5. Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, Wappenschmidt B, Hubbel V, Maringa M, Reichstein-Gnielinski S, Hahnen E, Bartram CR, Dikow N, Schott S, Speiser D, Horn D, Fallenberg EM, Kiechle M, Quante AS, Vesper AS, Fehm T, Mundhenke C, Arnold N, Leinert E, Just W, Siebers-Renelt U, Weigel S, Gehrig A, Wockel A, Schlegelberger B, Pertschy S, Kast K, Wimberger P, Briest S, Loeffler M, Bick U, Schmutzler RK (2020). Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer, 146(4), 999-1009.
     
  6. Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S (2020). From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol, 55(1), 5-12.
     
  7. Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S (2020). From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol, 55(1), 5-12.
     


  8. 2019


  9. Fischer M (2019). Conservation and divergence of the p53 gene regulatory network between mice and humans. Oncogene, 1, Epub.
     
  10. Schug S, Baunacke A, Goeckenjan M, Horn LC, Pretzsch G, Zimmermann G, Alexander H (2019). Endometrial human chorionic gonadotropin (hCG) expression is a marker for adequate secretory transformation of the endometrium. Arch Gynecol Obstet, 299, 1727-1736.
     
  11. Uxa S, Bernhart SH, Mages CFS, Fischer M, Kohler R, Hoffmann S, Stadler PF, Engeland K, Muller GA (2019). DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation. Nucleic Acids Res, 47, 9087-9103.
     
  12. Hockel M, Wolf B, Schmidt K, Mende M, Aktas B, Kimmig R, Dornhofer N, Horn LC (2019). Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study. Lancet Oncol, 20(9), 1316-1326.
     
  13. Kubitschke H, Wolf B, Morawetz E, Horn LC, Aktas B, Behn U, Hockel M, Kas J (2019). Roadmap to Local Tumour Growth: Insights from Cervical Cancer. Sci Rep, 9(1), 12768-.
     
  14. Hockel M, Behn U (2019). The Order of Cancer: A Theory of Malignant Progression by Inverse Morphogenesis. Front Oncol, 9, 416-.
     
  15. Dathan-Stumpf A, Vogel M, Jank A, Thiery J, Kiess W, Stepan H (2019). Reference intervals of serum lipids in the second and third trimesters of pregnancy in a Caucasian cohort: the LIFE Child study. Arch Gynecol Obstet, 300(6), 1531-1539.
     
  16. Schmitz J, Stepan H, Schrey-Petersen S, Hoffmann J (2019). [Does Lower Uterine Segment Thickness Measurement Improve Birth Planning After Previous Cesarean Section?] Z Geburtshilfe Neonatol, 223(6), 350-358.
     
  17. Hoffmann J, Exner M, Bremicker K, Grothoff M, Stumpp P, Stepan H (2019). Comparison of the lower uterine segment in pregnant women with and without previous cesarean section in 3?T MRI. BMC Pregnancy Childbirth, 19(1), 160-.
     
  18. Stepan H, Hund M, Dilba P, Sillman J, Schlembach D (2019). Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable? Clin Chem Lab Med, 57(9), 1339-1348.
     
  19. Bernstein U, Kaiser T, Stepan H, Jank A (2019). The immature platelet fraction in hypertensive disease during pregnancy. Arch Gynecol Obstet, 299(6), 1537-1543.
     
  20. Nitz U, Gluz O, Christgen M, Kates RE, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Lorenz-Salehi F, Krabisch P, Just M, Augustin D, Liedtke C, Chao C, Shak S, Wuerstlein R, (2019). Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. Breast Cancer Res Treat, 0, 0.
     
  21. Schott S, Heinzler J, Rippinger N, Bruckner T, Brucker J, Hoffmann J, Dornhofer N, Dinkic C, Seitz S, Rom J, Sohn C, Schott TC (2019). Adherence to gynecological screening impacted by experienced orthodontic treatment in childhood. Arch Gynecol Obstet, 299, 167-171.
     
  22. Petin K, Weiss R, Muller G, Garten A, Grahnert A, Sack U, Hauschildt S (2019). NAD metabolites interfere with proliferation and functional properties of THP-1 cells. Innate Immun, 25, 280-293.
     
  23. Kubitschke H, Wolf B, Morawetz E, Horn LC, Aktas B, Behn U, Hockel M, Kas J (2019). Roadmap to Local Tumour Growth: Insights from Cervical Cancer. Sci Rep, 9(1), 12768-.
     
  24. Hockel M, Wolf B, Schmidt K, Mende M, Aktas B, Kimmig R, Dornhofer N, Horn LC (2019). Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study. Lancet Oncol, 20(9), 1316-1326.
     
  25. Liu F, Dai S, Feng D, Peng X, Qin Z, Kearns AC, Huang W, Chen Y, Ergun S, Wang H, Rappaport J, Bryda EC, Chandrasekhar A, Aktas B, Hu H, Chang SL, Gao B, Qin X (2019). Versatile cell ablation tools and their applications to study loss of cell functions. Cell Mol Life Sci, 76(23), 4725-4743.
     
  26. Martin M, Loibl S, Hyslop T, De la Haba-Rodriguez J, Aktas B, Cirrincione CT, Mehta K, Barry WT, Morales S, Carey LA, Garcia-Saenz JA, Partridge A, Martinez-Janez N, Hahn O, Winer E, Guerrero-Zotano A, Hudis C, Casas M, Rodriguez-Martin C, Furlanetto J, Carrasco E, Dickler MN (2019). Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. Eur J Cancer, 117, 91-98.
     
  27. Banys-Paluchowski M, Witzel I, Aktas B, Fasching PA, Hartkopf A, Janni W, Kasimir-Bauer S, Pantel K, Schon G, Rack B, Riethdorf S, Solomayer EF, Fehm T, Muller V (2019). The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. Sci Rep, 9(1), 2318-.
     
  28. Nitz U, Gluz O, Christgen M, Kates RE, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Lorenz-Salehi F, Krabisch P, Just M, Augustin D, Liedtke C, Chao C, Shak S, Wuerstlein R, Kreipe HH, Harbeck N (2019). Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. Breast Cancer Res Treat, 175(1), 265-266.
     
  29. Findeklee S, Radosa JC, Mothes A, Younes S, Schafhaupt S, Stotz L, Sklavounos P, Solomayer EF, Radosa MP (2019). Patient satisfaction with personal patient care (PPC) in the inpatient treatment of endometriosis. Arch Gynecol Obstet, 25, 0.
     
  30. Findeklee S, Radosa JC, Schafhaupt S, Younes S, Radosa CG, Mothes A, Solomayer EF, Radosa MP (2019). Evaluating the use of Clavien-Dindo classification and Picker Patient Experience Questionnaire as quality indicators in gynecologic endoscopy. Arch Gynecol Obstet, 300(5), 1317-1324.
     
  31. Radosa JC, Radosa MP, Schweitzer PA, Radosa CG, Stotz L, Hamza A, Takacs Z, Lepper PM, Wagenpfeil S, Linxweiler M, Morinello E, Solomayer EF (2019). Impact of different intraoperative CO2 pressure levels (8 and 15 mmHg) during laparoscopic hysterectomy performed due to benign uterine pathologies on postoperative pain and arterial pCO2 : a prospective randomised controlled clinical trial. BJOG, 126(10), 1276-1285.
     
  32. Rippinger N, Heinzler J, Bruckner T, Brucker J, Dinkic C, Hoffmann J, Dornhofer N, Seitz S, Rom J, Sohn C, Schott TC, Schott S (2019). The impact of a cervical dysplasia diagnosis on individual cancer prevention habits over time: a bicentric case-control study. Arch Gynecol Obstet, 299(3), 847-855.
     
  33. Meyer HJ, Briest S, Schierle K, Surov A (2019). Rofo, 191(7), 653-654.
     
  34. Singer S, Danker H, Meixensberger J, Briest S, Dietz A, Kortmann RD, Stolzenburg JU, Kersting A, Roick J (2019). Structured multi-disciplinary psychosocial care for cancer patients and the perceived quality of care from the patient perspective: a cluster-randomized trial. J Cancer Res Clin Oncol, 145(11), 2845-2854.
     
  35. Buttner M, Konig HH, Lobner M, Briest S, Konnopka A, Dietz A, Riedel-Heller S, Singer S (2019). Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study. Support Care Cancer, 27(6), 2221-2228.
     
  36. Steinke H, Wiersbicki D, Volker A, Pieroh P, Kulow C, Wolf B, Osterhoff G (2019). The fascial connections of the pectineal ligament. Clin Anat, 32(7), 961-969.
     
  37. Engesser D, Krauss O, Briest S, Stolzenburg J-U und Singer S: (2019). "Für mich ein Fremdwort, dass ich bisher nicht gehört habe? ? was Krebspatienten unter dem Begriff psychosoziale Unterstützung verstehen Der Onkologie Psychoonkologie, 25, 802-810.
     
  38. Horn LC, Handzel R, Borte G, Siebolts U, Haak A, Brambs CE (2019). Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma. J Cancer Res Clin Oncol, 145(10), 2573-2582.
     
  39. Horn LC, Handzel R, Borte G, Siebolts U, Haak A, Brambs CE (2019). Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma. J Cancer Res Clin Oncol, 145(10), 2573-2582.
     
  40. Lehnig F, Nagl M, Stepan H, Wagner B, Kersting A (2019). Associations of postpartum mother-infant bonding with maternal childhood maltreatment and postpartum mental health: a cross-sectional study. BMC Pregnancy Childbirth, 19(1), 278-.
     
  41. Seidel V, Gurbuz B, Grosskreutz C, Vortel M, Borde T, Rancourt RC, Stepan H, Sauzet O, Henrich W, David M (2019). The influence of migration on women's use of different aspects of maternity care in the German health care system: Secondary analysis of a comparative prospective study with the Migrant Friendly Maternity Care Questionnaire (MFMCQ). Birth, 3, 555-567.
     
  42. Schramm K, Grassl N, Nees J, Hoffmann J, Stepan H, Bruckner T, Haun MW, Maatouk I, Haist M, Schott TC, Sohn C, Schott S (2019). Women's Attitudes Toward Self-Monitoring of Their Pregnancy Using Noninvasive Electronic Devices: Cross-Sectional Multicenter Study. JMIR Mhealth Uhealth, 7(1), 11458-.
     
  43. Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Schoedl M, Grill S, Hund M, Verlohren S (2019). Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound Obstet Gynecol, 53(3), 367-375.
     
  44. Lewis CA, Kimmig AS, Zsido RG, Jank A, Derntl B, Sacher J (2019). Effects of Hormonal Contraceptives on Mood: A Focus on Emotion Recognition and Reactivity, Reward Processing, and Stress Response. Curr Psychiatry Rep, 21(11), 115-.
     
  45. Groten T, Lehmann T, Schleussner E (2019). Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial. BMC Pregnancy Childbirth, 19(1), 336-.
     


  46. 2018


  47. Engeland K (2018). Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ, 25(1), 114-132.
     
  48. Hockel M, Trott S, Dornhofer N, Horn LC, Hentschel B, Wolf B (2018). Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial. Lancet Oncol, 19(4), 537-548.
     
  49. Dornhöfer N, Aktas B (2018). Vulvafeldresektion mit therapeutischer Lymphonodektomie und anatomischer Rekonstruktion Journal Onkologie, 11, 47-56.
     
  50. Kreklau A, Vaz I, Oehme F, Strub F, Brechbuhl R, Christmann C, Gunthert A (2018). Measurements of a 'normal vulva' in women aged 15-84: a cross-sectional prospective single-centre study. BJOG, 125(13), 1656-1661.
     
  51. Kreklau A, Lopez Benitez R, Fornaro J, Meili G, Gunthert A (2018). Computer Tomography-Guided Percutaneous Indocyanine Green Injection for Intraoperative Mapping of Metastatic Suspected Lesions. Front Med (Lausanne), 5, 191-.
     
  52. Kreklau A, Aktas B (2018). Molekulare Heterogenität des HER2-positiven Mammakarzinoms Der Gynäkologe, 0, 0.
     
  53. Kreklau A, Aktas B (2018). Prognostische und prädiktive Faktoren und ihre therapeutischen Konsequenzen Ärztliches Journal, 0, 0.
     
  54. Steinke H, Wiersbicki D, Speckert ML, Merkwitz C, Wolfskampf T, Wolf B (2018). Periodic acid-Schiff (PAS) reaction and plastination in whole body slices. A novel technique to identify fascial tissue structures. Ann Anat, 216, 29-35.
     
  55. Hoffmann J, Exner M, Bremicker K, Grothoff M, Stumpp P, Schrey-Petersen S, Stepan H (2018). Cesarean section scar in 3 T magnetic resonance imaging and ultrasound: image characteristics and comparison of the methods. Arch Gynecol Obstet, 0, 0.
     
  56. Grafe D, Gutberlet M, Mende M, Dahnert I, Lucke C, Kostelka M, Nitzsche S, Hoffmann J, Grothoff M (2018). Cross-sectional Areas of the Thoracic Aorta in Children and Adolescents With Repaired Tetralogy of Fallot Obtained by Cardiac Magnetic Resonance Angiography. J Thorac Imaging, 33(2), 105-111.
     
  57. Wolf B, Krasselt M, de Fallois J, von Braun A, Stepan H (2018). Tuberculosis in Pregnancy ? a Summary Geburtshilfe und Frauenheilkunde, 0, 01-19.
     
  58. Schmitz J, Stepan H, Schrey-Petersen S, Hoffmann J (2018). Verbessert die Diagnostik des unteren Uterinsegments die Geburtsplanung bei Status nach Sectio? Zeitschrift für Geburtshilfe und Perinatologie, 0, 0.
     
  59. Weber ML, Schaarschmidt W, Thadhani R, Stepan H (2018). Cerebroplacental ratio and fetal response to maternal extracorporeal soluble fms-like tyrosine kinase-1 removal. Ultrasound Obstet Gynecol, 52(3), 405-406.
     
  60. Hoffmann J, Stumpp P, Exner M, Grothoff M, Stepan H (2018). Magnetic resonance imaging can be useful for advanced diagnostic of the lower uterine segment in patients after previous cesarean section. Ultrasound Obstet Gynecol, 0, 0.
     
  61. Weber ML (2018). [Can Pravastatin influence Pregnancies at High-risk for Preeclampsia?] Z Geburtshilfe Neonatol, 222(1), 31-33.
     
  62. Dathan-Stumpf A, Faber R, Stepan H (2018). Abnorm invasive Plazenta: klinisches Management Frauenarzt 2018, 9, 674–677.
     
  63. Dathan-Stumpf A (2018). Adipositas und andere Einflussgrößen auf die sonographische Schätzgenauigkeit makrosomer Neugeborener Adipositas, 0, 0.
     
  64. Heihoff-Klose A (2018). Wie steht es um die Episiotomie in der Geburtsmedizin? Bayerisches Ärzteblatt, 10, 0.
     
  65. Hanschmidt F, Hoffmann R, Klingner J, Kersting A, Stepan H (2018). Help-seeking Following Termination of Pregnancy after Diagnosis of Fetal Anomaly: Womens Intentions and Experiences 1 to 7 Years after the Event. Geburtshilfe Frauenheilkd, 78, 160-166.
     
  66. Frömberg A, Engeland K, Aigner A (2018). The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors. Cancer Lett, 417, 96-111.
     
  67. Roick J, Danker H, Kersting A, Briest S, Dietrich A, Dietz A, Einenkel J, Papsdorf K, Lordick F, Meixensberger J, Mössner J, Niederwieser D, Prietzel T, Schiefke F, Stolzenburg J, Wirtz H, Singer S (2018). Factors Associated with Non-Participation and Dropout Among Cancer Patients in a Cluster-randomised Controlled Trial. Eur J Cancer Care (Engl), 27(1), 12645.
     
  68. Sarabhai T, Schaarschmidt BM, Wetter A, Kirchner J, Aktas B, Forsting M, Ruhlmann V, Herrmann K, Umutlu L, Grueneisen J (2018). Comparison of 18F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix. Eur J Nucl Med Mol Imaging, 45(1), 67-76.
     
  69. Persaud L, Mighty J, Zhong X, Francis A, Mendez M, Muharam H, Redenti SM, Das D, Aktas BH, Sauane M (2018). IL-24 Promotes Apoptosis through cAMP-Dependent PKA Pathways in Human Breast Cancer Cells. Int J Mol Sci, 19(11), 0.
     
  70. Keup C, Mach P, Aktas B, Tewes M, Kolberg HC, Hauch S, Sprenger-Haussels M, Kimmig R, Kasimir-Bauer S (2018). RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients. Clin Chem, 64(7), 1054-1062.
     
  71. Banys-Paluchowski M, Fehm T, Janni W, Aktas B, Fasching PA, Kasimir-Bauer S, Milde-Langosch K, Pantel K, Rack B, Riethdorf S, Solomayer EF, Witzel I, Muller V (2018). Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. BMC Cancer, 18(1), 0.
     
  72. Banys-Paluchowski M, Fehm T, Janni W, Aktas B, Fasching PA, Kasimir-Bauer S, Milde-Langosch K, Pantel K, Rack B, Riethdorf S, Solomayer EF, Witzel I, Muller V (2018). Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer. BMC Cancer, 18(1), 0.
     
  73. Gluz O, Nitz U, Liedtke C, Christgen M, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Bangemann N, Lindner C, Kuemmel S, Clemens M, Potenberg J, Staib P, Kohl (2018). Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. J Natl Cancer Inst, 110(6), 628-637.
     
  74. Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L (2018). Comparison of 18F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study. Eur J Nucl Med Mol Imaging, 45(4), 622-629.
     
  75. Hockel M, Trott S, Dornhofer N, Horn LC, Hentschel B, Wolf B (2018). Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial. Lancet Oncol, 19(4), 537-548.
     
  76. Steinke H, Wiersbicki D, Speckert ML, Merkwitz C, Wolfskampf T, Wolf B (2018). Periodic acid-Schiff (PAS) reaction and plastination in whole body slices. A novel technique to identify fascial tissue structures. Ann Anat, 216, 29-35.
     
  77. Horn LC, Opitz S, Handzel R, Brambs CE (2018). [Histopathology and clinical aspects of extrauterine pregnancy]. Pathologe, 39(5), 431-444.
     
  78. Harbeck N, Luftner D, Marschner N, Untch M, Augustin D, Briest S, Ettl J, Haidinger R, Muller L, Muller V, Ruckhaberle E, Wuerstlein R, Thomssen C (2018). ABC4 Consensus: Assessment by a German Group of Experts. Breast Care (Basel), 13(1), 48-58.
     
  79. Untch M, Wurstlein R, Marschner N, Luftner D, Augustin D, Briest S, Ettl J, Haidinger R, Muller L, Muller V, Ruckhaberle E, Harbeck N, Thomssen C (2018). 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts. Geburtshilfe Frauenheilkd, 78(5), 469-480.
     
  80. Engel C, Rhiem K, Hahnen E, Loibl S, Weber KE, Seiler S, Zachariae S, Hauke J, Wappenschmidt B, Waha A, Blumcke B, Kiechle M, Meindl A, Niederacher D, Bartram CR, Speiser D, Schlegelberger B, Arnold N (2018). Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history. BMC Cancer, 18(1), 0.
     
  81. Singer S, Roick J, Meixensberger J, Schiefke F, Briest S, Dietz A, Papsdorf K, Mossner J, Berg T, Stolzenburg JU, Niederwieser D, Keller A, Kersting A, Danker H (2018). The effects of multi-disciplinary psycho-social care on socio-economic problems in cancer patients: a cluster-randomized trial. Support Care Cancer, 26(6), 1851-1859.
     
  82. Heinzler J, Brucker J, Bruckner T, Dinkic C, Hoffmann J, Dornhofer N, Seitz S, Sohn C, Rom J, Schott TC, Schott S (2018). Impact of a cervical dysplasia and its treatment on quality of life and sexual function. Arch Gynecol Obstet, 298(4), 737-745.
     
  83. Banys-Paluchowski M, Witzel I, Riethdorf S, Pantel K, Rack B, Janni W, Fasching PA, Aktas B, Kasimir-Bauer S, Hartkopf A, Solomayer EF, Fehm T, Muller V (2018). The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer. Breast Cancer Res Treat, 0, 0.
     
  84. Keup C, Mach P, Aktas B, Tewes M, Kolberg HC, Hauch S, Sprenger-Haussels M, Kimmig R, Kasimir-Bauer S (2018). RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients. Clin Chem, 64(7), 1054-1062.
     
  85. Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Schoedl M, Grill S, Hund M, Verlohren S (2018). The sFlt-1/PlGF Ratio: ruling out pre-eclampsia for up to 4 weeks and the value of retesting. Ultrasound Obstet Gynecol, 0, 0.
     
  86. Hammersen J, Wohlfart S, Goecke TW, Koninger A, Stepan H, Gallinat R, Morris S, Bucher K, Clarke A, Wunsche S, Beckmann MW, Schneider H, Faschingbauer F (2018). Reliability of prenatal detection of X-linked hypohidrotic ectodermal dysplasia by tooth germ sonography. Prenat Diagn, 0, 0.
     
  87. Hanschmidt F, Nagl M, Klingner J, Stepan H, Kersting A (2018). Abortion after diagnosis of fetal anomaly: Psychometric properties of a German version of the individual level abortion stigma scale. PLoS One, 13, 0.
     
  88. Hanschmidt F, Treml J, Klingner J, Stepan H, Kersting A (2018). Stigma in the context of pregnancy termination after diagnosis of fetal anomaly: associations with grief, trauma, and depression. Arch Womens Ment Health, 21, 391-399.
     
  89. Heinzler J, Brucker J, Bruckner T, Dinkic C, Hoffmann J, Dornhofer N, Seitz S, Sohn C, Rom J, Schott TC, Schott S (2018). Impact of a cervical dysplasia and its treatment on quality of life and sexual function. Arch Gynecol Obstet, 298, 737-745.
     
  90. Hanschmidt F, Hoffmann R, Klingner J, Kersting A, Stepan H (2018). Help-seeking Following Termination of Pregnancy after Diagnosis of Fetal Anomaly: Women's Intentions and Experiences 1 to 7 Years after the Event. Geburtshilfe Frauenheilkd, 78, 160-166.
     
  91. Grafe D, Gutberlet M, Mende M, Dahnert I, Lucke C, Kostelka M, Nitzsche S, Hoffmann J, Grothoff M (2018). Cross-sectional Areas of the Thoracic Aorta in Children and Adolescents With Repaired Tetralogy of Fallot Obtained by Cardiac Magnetic Resonance Angiography. J Thorac Imaging, 33(2), 105-111.
     
  92. Wolf B (2018). Entwicklungsgeschichte und Anatomie der Vulva und Vagina In: Schürich et al., Tumorerkrankungen der Vulva und Vagina (S. 3-13), Heidelberg: Springer Verlag.
     
  93. Wolf B (2018). Vulvafeldresektion In: Schürich et al., Tumorerkrankungen der Vulva und Vagina (S. 110-121), Heidelberg: Springer Verlag.
     
  94. Stepan H, Hoffmann J (2018). Part no. V/ 11 Prediction of preeclampsia ? sFlt-1/ PLGF In: Shigeru Saito , Comprehensive Gynecology and Obstetrics - Preeclampsia (S. 175-198), Berlin: Springer Verlag.
     


  95. 2017


  96. Muller GA, Stangner K, Schmitt T, Wintsche A, Engeland K (2017). Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression. Oncotarget, 8(58), 97736-97748.
     
  97. Hockel M, Wolf B, Hentschel B, Horn LC (2017). Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis. Eur J Cancer, 70, 99-110.
     
  98. Fischer M (2017). Census and evaluation of p53 target genes. Oncogene, 36(28), 3943-3956.
     
  99. Fischer M, Uxa S, Stanko C, Magin TM, Engeland K (2017). Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway. Sci Rep, 7(1), 2603.
     
  100. Mages CF, Wintsche A, Bernhart SH, Müller GA (2017). The DREAM complex through its subunit Lin37 cooperates with Rb to initiate quiescence. Elife, 6, e26876.
     
  101. Ratsch U, Kaiser T, Stepan H, Jank A (2017). Evaluation of bone marrow function with immature platelet fraction in normal pregnancy. Pregnancy Hypertens, 10, 70-73.
     
  102. Schrey-Petersen S, Stepan H (2017). Anti-angiogenesis and Preeclampsia in 2016. Curr Hypertens Rep, 19(1), 6.
     
  103. Wolf B, Monecke, A, Horn, LC, Thome U, Stepan H, Schrey-Petersen S (2017). Acute lymphoblastic congenital leukemia as a cause of perinatal death following massive cerebral hemorrhage. Case Reports in Perinatal Medicine, 6(1), 0053.
     
  104. Hoffmann J, Ossada V, Weber M, Stepan H (2017). An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome. Pregnancy Hypertens, 10, 165-170.
     
  105. Faber R, Stepan H (2017). Sonografische Beurteilung des unteren Uterinsegments in der Schwangerschaft. Frauenarzt, 58(10), 825-833.
     
  106. Verlohren S, Stepan H (2017). Re: Rational and irrational ratios. Ultrasound in Obstetrics and Gynecology , 49(1), 157-158.
     
  107. Weber M, Stepan H (2017). ASS und Heparin zur Prävention der Präeklampsie. Gynaekologische Praxis , 42, 212-218.
     
  108. Berg K, Kraemer JF, Riedl M, Stepan H, Kurths J, Wessel N (2017). Increased cardiorespiratory coordination in preeclampsia. Physiol Meas, 38(5), 912-924.
     
  109. Kimmig R, Buderath P, Rusch P, Mach P, Aktas B (2017). Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part). J Gynecol Oncol, 28(5), 68.
     
  110. Kimmig R, Buderath P, Rusch P, Aktas B (2017). Technique of ICG-guided Targeted Compartmental Pelvic Lymphadenectomy (TCL) combined with Pelvic Peritoneal Mesometrial Resection (PMMR) for locoregional control of endometrial cancer - A proposal. Gynecol Oncol Rep, 20, 125-126.
     
  111. Kimmig R, Buderath P, Mach P, Rusch P, Aktas B (2017). Surgical treatment of early ovarian cancer with compartmental resection of regional lymphatic network and indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, paraaortic part). J Gynecol Oncol, 28(3), 41.
     
  112. Kimmig R, Rusch P, Buderath P, Aktas B (2017). Aortic utero-ovarian sentinel nodes and left infrarenal aortic lymph node dissection by ICG supported navigation. Gynecol Oncol Rep, 20, 22-23.
     
  113. Kimmig R, Buderath P, Rusch P, Aktas B (2017). Surgical anatomy of the ligamentous mesometrium and robotically assisted ICG-guided resection in cervical cancer. Gynecol Oncol Rep, 20, 4.
     
  114. Bredemeier M, Kasimir-Bauer S, Kolberg HC, Herold T, Synoracki S, Hauch S, Edimiris P, Bankfalvi A, Tewes M, Kimmig R, Aktas B (2017). Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer. Mol Med Rep, 15(5), 2957-2968.
     
  115. Wolf B, Ganzer R, Stolzenburg JU, Hentschel B, Horn LC, Hockel M (2017). Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields. Gynecol Oncol, 146(2), 292-298.
     
  116. Wolf B, Horn LC, Hockel M (2017). Anogenital lichen sclerosus: Change of tissue position as pathogenetic factor. Gynecol Oncol Rep, 20, 73-74.
     
  117. Wolf B, Kunert C, Horn LC, Einenkel J (2017). Management of Primary Retroperitoneal Mucinous Tumors: A Retrospective Meta-Analysis. Int J Gynecol Cancer, 27(6), 1064-1071.
     
  118. Singer S, Bartels M, Briest S, Einenkel J, Niederwieser D, Papsdorf K, Stolzenburg JU, Kunstler S, Taubenheim S, Krauss O (2017). Socio-economic disparities in long-term cancer survival-10 year follow-up with individual patient data. Support Care Cancer, 25(5), 1391-1399.
     
  119. Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L (2017). Comparison of 18F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study. Eur J Nucl Med Mol Imaging, 00, 00.
     
  120. Liu Y, Chen S, Wang S, Soares F, Fischer M, Meng F, Du Z, Lin C, Meyer C, DeCaprio JA, Brown M, Liu XS, He HH (2017). Transcriptional landscape of the human cell cycle. Proc Natl Acad Sci U S A, 114(13), 3473-3478.
     
  121. Nitz U, Gluz O, Christgen M, Kates RE, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Lorenz-Salehi F, Krabisch P, Just M, Augustin D, Liedtke C, Chao C, Shak S, Wuerstlein R, (2017). Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. Breast Cancer Res Treat, 165(3), 573-583.
     
  122. Singer S , Roick J, Meixensberger J, Schiefke F, Briest S, Dietz A, Papsdorf K, Mossner J, Berg T, Stolzenburg J, Niederwieser D, Keller A, Kersting A, Danker H (2017). The effects of multi-disciplinary psycho-social care on socio-economic problems in cancer partients: a cluster-randomized trial. Support Care Cancer, 00, 00.
     
  123. Banys-Paluchowski M, Witzel I, Riethdorf S, Rack B, Janni W, Fasching PA, Solomayer EF, Aktas B, Kasimir-Bauer S, Pantel K, Fehm T, Muller V (2017). Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients. Anticancer Res, 37(6), 3117-3128.
     
  124. Banys-Paluchowski M, Witzel I, Riethdorf S, Rack B, Janni W, Fasching PA, Solomayer EF, Aktas B, Kasimir-Bauer S, Pantel K, Fehm T, Muller V (2017). Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer. Sci Rep, 7(1), 17307.
     
  125. Bredemeier M, Edimiris P, Mach P, Kubista M, Sjoback R, Rohlova E, Kolostova K, Hauch S, Aktas B, Tewes M, Kimmig R, Kasimir-Bauer S (2017). Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic Breast Cancer. Clin Chem, 63(10), 1585-1593.
     
  126. Furlanetto J, Jackisch C, Untch M, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Wiebringhaus H, Kummel S, Warm M, Paepke S, Just M, Hanusch C, Hackmann J, Blohmer JU, Clemens M, Costa SD, Gerber B (2017). Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69). Breast Cancer Res Treat, 163(3), 495-506.
     
  127. Gluz O, Nitz U, Liedtke C, Christgen M, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Bangemann N, Lindner C, Kuemmel S, Clemens M, Potenberg J, Staib P, Kohl (2017). Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. J Natl Cancer Inst, 00, 00.
     
  128. Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L (2017). Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients. Eur J Radiol, 89, 14-19.
     
  129. Harbeck N, Gluz O, Christgen M, Kates RE, Braun M, Kuemmel S, Schumacher C, Potenberg J, Kraemer S, Kleine-Tebbe A, Augustin D, Aktas B, Forstbauer H, Tio J, von Schumann R, Liedtke C, Grischke EM, Sc (2017). De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. J Clin Oncol, 35(26), 3046-3054.
     
  130. Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, Deuschl C, Herrmann K, Antoch G, Forsting M, Umutlu L (2017). Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT. PLoS One, 12(2), e0172553.
     
  131. Kolberg HC, Aktas B, Liedtke C (2017). Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer. Rev Recent Clin Trials, 12(2), 67-72.
     
  132. Nagl M, Lehnig F, Stepan H, Wagner B, Kersting A (2017). Associations of childhood maltreatment with pre-pregnancy obesity and maternal postpartum mental health: a cross-sectional study. BMC Pregnancy Childbirth, 17(1), 391.
     
  133. Vatish M, Stepan H, Hund M, Verlohren S (2017). Re: Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks gestation. Ultrasound Obstet Gynecol, 49(5), 665-666.
     
  134. Loibl S, Jackisch C, Schneeweis A, Schmalloch S, Aktas B, Denkert C, Wiebringhaus H, Kümmel S, Warm M, Paepke S, Just M, Hanusch C, Hackmann J, Blohmer JU, Clemens M, Dan Costa S, Gerber B, Engels K, (2017). investigators of the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynäkologische Onkologie-Breast (AGO-B) study Groups. Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized Phase III GeparSepto Trial. Ann Oncol, 28(3), 497-504.
     
  135. Singer S, Danker H, Roick J, Einenkel J, Briest S, Spieker H, Dietz A, Hoffmann I, Papsdorf K, Meixensberger J, Mossner J, Schiefke F, Dietel A, Wirtz H, Niederwieser D, Berg T, Kersting A (2017). Effects of stepped psycho-oncological care on referral to psychosocial services and emotional well-being in cancer patients: A cluster-randomised phase III trial. Psycho-Oncology , 26(10), 1675-1683.
     
  136. Berg K, Kraemer JF, Riedl M, Stepan H, Kurths J, Wessel N (2017). Increased cardiorespiratory coordination in preeclampsia. Physiol Meas, 38(5), 912-924.
     
  137. Kehl S, Dotsch J, Hecher K, Schlembach D, Schmitz D, Stepan H, Gembruch U (2017). Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No.?015/080, October 2016). Geburtshilfe Frauenheilkd, 77, 1157-1173.
     
  138. Hockel M, Wolf B, Hentschel B, Horn LC (2017). Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis. Eur J Cancer, 70, 99-110.
     
  139. Wolf B, Dornhöfer N (2017). 101: Total and Peritoneal Mesometrial Resection. In: Alkatout, Meinhold-Heerlein, Mettler, Hysterectomy - A Comprehensive Surgical Approach. (S. 1243-1262), Berlin: Springer Verlag .
     
  140. Schlembach D, Schleußner E, Stepan H (2017). Klinische Geburtsmedizin. In: Schlembach D., Schleußner, E., Stepan H, Klinische Geburtsmedizin. (S. 118), Berlin/ Boston: De Gruyter Verlag.
     


  141. 2016


  142. Fischer M, Quaas M, Steiner L, Engeland K (2016). The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes. Nucleic Acids Res, 44(1), 164-174.
     
  143. Ossada V, Jank A, Stepan H (2016). The impact of uterine curettage postpartum on maternal sFlt-1 concentration. J Perinat Med, 44(3), 351-354.
     
  144. Meinert C, Gembardt F, Bohme I, Tetzner A, Wieland T, Greenberg B, Walther T (2016). Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7). J Proteomics, 130, 129-139.
     
  145. Engeland K (2016). Stopping cells from dividing. Editorial. Aging (Albany NY), 8(3), 425-426.
     
  146. Fischer M, Grossmann P, Padi M, DeCaprio JA (2016). Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucleic Acids Res, 44(13), 6070-6086.
     
  147. Fischer M (2016). p21 governs p53s repressive side. Editorial. Cell Cycle, 15(21), 2852-2853.
     
  148. Klein E, Schlembach D, Ramoni A, Langer E, Bahlmann F, Grill S, Schaffenrath H, van der Does R, Messinger D, Verhagen-Kamerbeek WD, Reim M, Hund M, Stepan H (2016). Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia. PLoS One, 11(5), e0156013.
     
  149. Hoffmann J, Thomassen K, Stumpp P, Grothoff M, Engel C, Kahn T, Stepan H (2016). New MRI Criteria for Successful Vaginal Breech Delivery in Primiparae. PLoS One, 11(8), e0161028.
     
  150. Stepan H, Hund M, Gencay M, Denk B, Dinkel C, Kaminski WE, Wieloch P, Semus B, Meloth T, Droge LA, Verlohren S (2016). A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome. Hypertens Pregnancy, 35(3), 295-305.
     
  151. Hoffmann J, Stepan H (2016). Bildgebende Diagnostik bei Zustand nach Sectio. Ther Umsch, 73(7), 425-430.
     
  152. Schrey S, Stepan H (2016). Pränatale epigenetische Prägung: Stand des Wissens. Dtsch Arztebl, 113(45), 2040-2044.
     
  153. Aktas B, Kasimir-Bauer S, Muller V, Janni W, Fehm T, Wallwiener D, Pantel K, Tewes M (2016). Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients. BMC Cancer, 16, 522.
     
  154. Kimmig R, Rusch P, Buderath P, Aktas B (2016). Left paraaortic, inframesenteric lymphadenectomy preserving the superior hypogastric plexus supported by indocyanine green (ICG) labeling of the lymphatic compartment in cervical cancer. Gynecol Oncol Rep, 18, 14.
     
  155. Aktas B, Sorkin M, Pusztai L, Hofstatter EW (2016). Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer. Eur J Cancer Prev, 25(1), 3-8.
     
  156. Exner M, Kuhn A, Stumpp P, Hockel M, Horn LC, Kahn T, Brandmaier P (2016). Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment. Acta Radiol, 57(7), 869-877.
     
  157. Nagl M, Steinig J, Klinitzke G, Stepan H, Kersting A (2016). Childhood maltreatment and pre-pregnancy obesity: a comparison of obese, overweight, and normal weight pregnant women. Arch Womens Ment Health, 19(2), 355-365.
     
  158. Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T (2016). Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. J Am Soc Nephrol, 27(3), 903-913.
     
  159. Singer J, Jank A, Amara S, Stepan PD, Kaisers U, Hoehne C (2016). Efficacy and Effects of Parenteral Pethidine or Meptazinol and Regional Analgesia for Pain Relief during Delivery. A Comparative Observational Study. Geburtshilfe Frauenheilkd, 76(9), 964-971.
     
  160. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S (2016). Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med, 374(1), 13-22.
     
  161. Burke O, Benton S, Szafranski P, von Dadelszen P, Buhimschi SC, Cetin I, Chappell L, Figueras F, Galindo A, Herraiz I, Holzman C, Hubel C, Knudsen U, Kronborg C, Laivuori H, Lapaire O, McElrath T, Moe (2016). Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms. Pregnancy Hypertens, 6(1), 53-59.
     
  162. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dinkel C, Schoedl M, Dilba P, Hund M, Verlohren S (2016). Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia. Obstet Gynecol, 128(2), 261-269.
     
  163. Mozet C, Kuhnt T, Sattler B, Remmele J, Thome U, Stepan H, Kluge R, Dietz A, Knoedler M (2016). [Head and Neck Cancer in Pregnancy - Recommendations for Diagnosis and Therapy With Case Report]. Laryngorhinootologie, 95(10), 674-683.
     
  164. Singer S, Roick J, Briest S, Stark S, Gockel I, Boehm A, Papsdorf K, Meixensberger J, Muller T, Prietzel T, Schiefke F, Dietel A, Braunlich J, Danker H (2016). Impact of socio-economic position on cancer stage at presentation: Findings from a large hospital-based study in Germany. Int J Cancer, 139(8), 1696-1702.
     
  165. Tempfer C, Horn LC, Ackermann S, Beckmann MW, Dittrich R, Einenkel J, Gunthert A, Haase H, Kratzsch J, Kreissl MC, Polterauer S, Ebert AD, Schneider KT, Strauss HG, Thiel F (2016). Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No.?032/049, December 2015). Geburtshilfe Frauenheilkd, 76(2), 134-144.
     
  166. Horn LC, Mayr D, Brambs CE, Einenkel J, Sandig I, Schierle K (2016). [Grading of gynecological tumors : Current aspects]. Pathologe, 37(4), 337-351.
     
  167. Horn LC, Brambs CE, Handzel R, Lax S, Sandig I, Schmidt D, Schierle K (2016). [Cervical cancer : Update on morphology]. Pathologe, 37(6), 542-548.
     
  168. Horn LC, Brambs CE, Handzel R, Mehlhorn G, Schmidt D, Schierle K (2016). [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects]. Pathologe, 37(6), 526-533.
     
  169. Nagl M, Steinig J, Klinitzke G, Stepan H, Kersting A (2016). Childhood maltreatment and pre-pregnancy obesity: a comparison of obese, overweight, and normal weight pregnant women. Arch Womens Ment Health, 19(2), 355-365.
     
  170. Bredemeier M, Edimiris P, Tewes M, Mach P, Aktas B, Schellbach D, Wagner J, Kimmig R, Kasimir-Bauer S (2016). Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment. Oncotarget, 7(27), 41677-41690.
     
  171. Buderath P, Kasimir-Bauer S, Aktas B, Rasch J, Kimmig R, Zeller T, Heubner M (2016). Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancer. Future Sci OA, 2(4), 145.
     
  172. Gluz O, Nitz UA, Christgen M, Kates RE, Shak S, Clemens M, Kraemer S, Aktas B, Kuemmel S, Reimer T, Kusche M, Heyl V, Lorenz-Salehi F, Just M, Hofmann D, Degenhardt T, Liedtke C, Svedman C, Wuerstlein (2016). West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment. J Clin Oncol, 34(20), 2341-2349.
     
  173. Kasimir-Bauer S, Reiter K, Aktas B, Bittner AK, Weber S, Keller T, Kimmig R, Hoffmann O (2016). Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake? Sci Rep, 6, 26355.
     
  174. Kimmig R, Iannaccone A, Aktas B, Buderath P, Heubner M (2016). Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacy. Arch Gynecol Obstet, 294(1), 153-160.
     
  175. Kimmig R, Aktas B, Buderath P, Heubner M (2016). Robotically assisted peritoneal mesometrial resection (PMMR) in endometrial cancer supported by ICG labeling of the compartmental lymphatic system. Gynecol Oncol Rep, 16, 24.
     
  176. Kimmig R, Aktas B, Buderath P, Rusch P, Heubner M (2016). Intraoperative navigation in robotically assisted compartmental surgery of uterine cancer by visualisation of embryologically derived lymphatic networks with indocyanine-green (ICG). J Surg Oncol, 113(5), 554-559.
     
  177. Kolberg HC, Akpolat-Basci L, Stephanou M, Aktas B, Hannig CV, Liedtke C (2016). Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over 4 Years. Breast Care (Basel), 11(5), 323-327.
     
  178. Schneeweiss A, Forster F, Tesch H, Aktas B, Gluz O, Geberth M, Hertz-Eichenrode MM, Schonegg W, Schumacher C, Kutscheidt A, Kiewitz C, Klawitter S, Schmidt M (2016). First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study. Anticancer Res, 36(3), 967-974.
     
  179. Untch M, Jackisch C, Schneeweiss A, Conrad B, Aktas B, Denkert C, Eidtmann H, Wiebringhaus H, Kummel S, Hilfrich J, Warm M, Paepke S, Just M, Hanusch C, Hackmann J, Blohmer JU, Clemens M, Darb-Esfahan (2016). Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial. Lancet Oncol, 17(3), 345-356.
     
  180. Kimmig R, Aktas B, Rusch P, Heubner M (2016). ICG-gestützte Navigation bei der Chirurgie uteriner Malignome. Der Gynäkologe, 49(5), 373-379.
     
  181. Stangner T, Wagner C, Gutsche C, Stangner K, Singer D, Angioletti-Uberti S, Kremer F (2016). Probing receptor-ligand interactions on a single molecule level using optical tweezers. In: Ohshima H, Encyclopedia of Biocolloid and Biointerfacial Science. (S. 915-932), New York: John Wiley & Sons.
     
  182. Dornhöfer N (2016). Vulvakarzinom - Defektdeckung und anatomische Vulvarekonstruktion. In: Janni W, Gregorio N, Schwentner L, Kürzl R, Erkrankungen der Vulva. (S. 56-74), Berlin: Walter De Gruyter.
     
  183. Dornhöfer N, Wolf B (2016). Vulvakarzinom. In: Janni W, Gregorio N, Schwentner L, Kürzl R, Erkrankungen der Vulva. (S. 39-116), Berlin: Walter De Gruyter.
     


  184. 2015


  185. Fischer M, Quaas M, Nickel A, Engeland K (2015). Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex. Oncotarget, 6(39), 41402-41417.
     
  186. Fischer M, DeCaprio JA (2015). Does Arabidopsis thaliana DREAM of cell cycle control? EMBO J, 34(15), 1987-1989.
     
  187. Engeland K (2015). Simplify p53: just an activator. Editorial. Oncotarget, 6(1), 3-4.
     
  188. Hockel M (2015). Long-term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies. Curr Oncol Rep, 17(3), 435.
     
  189. Hockel M (2015). Morphogenetic fields of embryonic development in locoregional cancer spread. Lancet Oncol, 16(3), 148-151.
     
  190. Wolf B, Horn LC, Handzel R, Einenkel J (2015). Ultrasound plays a key role in imaging and management of genital angiomyofibroblastoma: a case report. J Med Case Rep, 9, 248.
     
  191. Schrey S, Wurst U, Ebert T, Kralisch S, Drewlo S, Stepan H, Lossner U, Platz M, Kratzsch J, Stumvoll M, Fasshauer M (2015). The adipokine preadipocyte factor-1 is downregulated in preeclampsia and expressed in placenta. Cytokine, 75(2), 338-343.
     
  192. Stepan H, Herraiz I, Schlembach D, Verlohren S, Brennecke S, Chantraine F, Klein E, Lapaire O, Llurba E, Ramoni A, Vatish M, Wertaschnigg D, Galindo A (2015). Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol, 45(3), 241-246.
     
  193. Hund M, Verhagen-Kamerbeek W, Reim M, Messinger D, van der Does R, Stepan H (2015). Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia-the PreOS study protocol. Hypertens Pregnancy, 34(1), 102-115.
     
  194. Tewes M, Kasimir-Bauer S, Welt A, Schuler M, Kimmig R, Aktas B (2015). Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer. J Cancer Res Clin Oncol, 141(1), 87-92.
     
  195. Händel C, Schmidt S, Schiller J, Dietrich U, Möhn T, Kießling T, Pawlizak S, Fritsch A, Horn LC, Briest S, Hockel M, Zink M, Käs J (2015). Cell membrane softening in human breast and cervical cancer cells. New Journal of Physics, 17, 083008.
     
  196. Wunsche S, Jungert J, Faschingbauer F, Mommsen H, Goecke T, Schwanitz K, Stepan H, Schneider H (2015). Noninvasive Prenatal Diagnosis of Hypohidrotic Ectodermal Dysplasia by Tooth Germ Sonography. Ultraschall Med, 36(4), 381-385.
     
  197. Droge L, Herraiz I, Zeisler H, Schlembach D, Stepan H, Kussel L, Henrich W, Galindo A, Verlohren S (2015). Maternal serum s-Flt-1/PlGF-ratio in twin pregnancies with and without preeclampsia in comparison to singleton pregnancies. Ultrasound Obstet Gynecol, 45(3), 286-293.
     
  198. Gross MM, Matterne A, Berlage S, Kaiser A, Lack N, Macher-Heidrich S, Misselwitz B, Bahlmann F, Falbrede J, Hillemanns P, von Kaisenberg C, von Koch FE, Schild RL, Stepan H, Devane D, Mikolajczyk R (2015). Interinstitutional variations in mode of birth after a previous caesarean section: a cross-sectional study in six German hospitals. J Perinat Med, 43(2), 177-184.
     
  199. Klein DK, Hoffmann S, Ahlskog JK, O Hanlon K, Quaas M, Larsen BD, Rolland B, Rosner HI, Walter D, Kousholt AN, Menzel T, Lees M, Johansen JV, Rappsilber J, Engeland K, Sorensen CS (2015). Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control. Nat Commun, 6, 5800.
     
  200. Preim U, Sommer P, Hoffmann J, Kehrmann J, Lehmkuhl L, Daehnert I, Gutberlet M, Grothoff M (2015). Delayed enhancement imaging in a contemporary patient cohort following correction of tetralogy of Fallot. Cardiol Young, 25(7), 1268-1275.
     
  201. Nagl M, Linde K, Stepan H, Kersting A (2015). Obesity and anxiety during pregnancy and postpartum: A systematic review. J Affect Disord, 186, 293-305.
     
  202. Brandmaier P, Purz S, Bremicker K, Hockel M, Barthel H, Kluge R, Kahn T, Sabri O, Stumpp P (2015). Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer. PLoS One, 10(11), e0141684.
     
  203. Platz M, Stepan H, Schrey S, Kralisch S, Wurst U, Lossner U, Jessnitzer B, Kratzsch J, Stumvoll M, Fasshauer M, Ebert T (2015). Serum levels of sclerostin in cardiometabolic disorders during pregnancy. Cytokine, 76(2), 591-593.
     
  204. Runge J, Riedl M, Muller A, Stepan H, Kurths J, Wessel N (2015). Quantifying the causal strength of multivariate cardiovascular couplings with momentary information transfer. Physiol Meas, 36(4), 813-825.
     
  205. Dhein S, Wermke A, von Salisch S, Schlegel F, Stepan H, Dohmen PM, Kostelka M, Mohr FW (2015). Autocrine control of angiogenesis by endogenous acetylcholine in an in vitro model using human endothelial cells: evidence for an autocrine cholinergic system in endothelial cells. J Cardiovasc Pharmacol, 65(5), 508-515.
     
  206. Klein S, Herath CB, Schierwagen R, Grace J, Haltenhof T, Uschner FE, Strassburg CP, Sauerbruch T, Walther T, Angus PW, Trebicka J (2015). Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis. PLoS One, 10(9), e0138732.
     
  207. Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P, Kraff O, Forsting M, Lauenstein TC, Umutlu L (2015). [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging, 42(1), 56-65.
     
  208. Grueneisen J, Schaarschmidt BM, Heubner M, Aktas B, Kinner S, Forsting M, Lauenstein T, Ruhlmann V, Umutlu L (2015). Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Eur J Nucl Med Mol Imaging, 42(12), 1814-1824.
     
  209. Luck HJ, Lubbe K, Reinisch M, Maass N, Feisel-Schwickardi G, Tome O, Janni W, Aydogdu M, Neunhoffer T, Ober A, Aktas B, Park-Simon TW, Schumacher C, Hoffkes HG, Illmer T, Wagner H, Mehta K, von Minckw (2015). Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer. Breast Cancer Res Treat, 149(1), 141-149.
     
  210. Martin M, Loibl S, von Minckwitz G, Morales S, Martinez N, Guerrero A, Anton A, Aktas B, Schoenegg W, Munoz M, Garcia-Saenz JA, Gil M, Ramos M, Margeli M, Carrasco E, Liedtke C, Wachsmann G, Mehta K, (2015). Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study. J Clin Oncol, 33(9), 1045-1052.
     
  211. Tewes M, Kasimir-Bauer S, Welt A, Schuler M, Kimmig R, Aktas B (2015). Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer. J Cancer Res Clin Oncol, 141(1), 87-92.
     
  212. Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Circuelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J, CLEOPATRA Study Group, Aktas B, et al (2015). Pertuzumab, trastuzumab and doxetacel in HER2-positive metastatic breast cancer. N Engl J Med, 372(8), 724-34.
     
  213. Birdir C, Aktas B, Kimmig R, Köninger A (2015). Präeklampsiescreening im ersten Trimenon. Der Gynäkologe, 48(5), 394-398.
     


  214. 2014


  215. Fischer M, Quaas M, Wintsche A, Muller GA, Engeland K (2014). Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein. Nucleic Acids Res, 42(1), 163-180.
     
  216. Muller GA, Wintsche A, Stangner K, Prohaska SJ, Stadler PF, Engeland K (2014). The CHR site: definition and genome-wide identification of a cell cycle transcriptional element. Nucleic Acids Res, 42(16), 10331-10350.
     
  217. Fischer M, Steiner L, Engeland K (2014). The transcription factor p53: not a repressor, solely an activator. Cell Cycle, 13(19), 3037-3058.
     
  218. Hockel M, Hentschel B, Horn LC (2014). Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol, 15(4), 445-456.
     
  219. Vochem R, Einenkel J, Horn LC, Ruschpler P (2014). [Importance of the tumor stem cell hypothesis for understanding ovarian cancer]. Pathologe, 35(4), 361-370.
     
  220. Engeland K (2014). Simplify p53: just an activator. Editorial. Oncotarget, 6(1), 3-4.
     
  221. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, Galindo A, Schoofs K, Denk B, Stepan H (2014). New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension, 63(2), 346-352.
     
  222. Schaarschmidt W, Stepan H (2014). Reply to: hepatic rupture - a rare but serious complication of HELLP syndrome. J Perinat Med, 42(2), 263-264.
     
  223. Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H (2014). Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth, 14, 324.
     
  224. Walther T, Voss A, Baumert M, Truebner S, Till H, Stepan H, Wessel N, Faber R (2014). Cardiovascular variability before and after delivery: recovery from arterial stiffness in women with preeclampsia 4days post partum. Hypertens Pregnancy, 33(1), 1-14.
     
  225. Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J (2014). [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients]. Z Geburtshilfe Neonatol, 218(1), 34-41.
     
  226. Kast K, Schmutzler RK, Rhiem K, Kiechle M, Bartram CR, Niederacher D, Arnold N, Grimm T, Speiser D, Schlegelberger B, Varga D, Horvath J, Beer M, Briest S, Meindl A, Engel C (2014). Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9.390 families suspected of having hereditary breast and ovarian cancer. Int J Cancer, 135(10), 2352-2361.
     
  227. Engeland CE, Brown NP, Borner K, Schumann M, Krause E, Kaderali L, Müller GA, Krausslich HG (2014). Proteome analysis of the HIV-1 Gag interactome. Virology, 460-461, 194-206.
     
  228. Hackermuller J, Reiche K, Otto C, Hosler N, Blumert C, Brocke-Heidrich K, Bohlig L, Nitsche A, Kasack K, Ahnert P, Krupp W, Engeland K, Stadler PF, Horn F (2014). Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs. Genome Biol, 15(3), R48.
     
  229. Singer S, Meyer A, Wienholz S, Briest S, Brown A, Dietz A, Binder H, Jonas S, Papsdorf K, Stolzenburg JU, Kohler U, Rassler J, Zwerenz R, Schroter K, Mehnert A, Lobner M, Konig HH, Riedel-Heller SG (2014). Early retirement in cancer patients with or without comorbid mental health conditions: a prospective cohort study. Cancer, 120(14), 2199-2206.
     
  230. Horn LC, Bilek K, Fischer U, Einenkel J, Hentschel B (2014). A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecol Oncol, 134(1), 42-46.
     
  231. Singer S, Danker H, Briest S, Dietrich A, Dietz A, Einenkel J, Papsdorf K, Lordick F, Meixensberger J, Mossner J, Niederwieser D, Prietzel T, Schiefke F, Stolzenburg JU, Wirtz H, Kersting A (2014). Effect of a structured psycho-oncological screening and treatment model on mental health in cancer patients (STEPPED CARE): study protocol for a cluster randomized controlled trial. Trials, 15, 482.
     
  232. Horn LC, Hohn AK, Einenkel J, Siebolts U (2014). Monoclonal origin of peritoneal implants and lymph node deposits in serous borderline ovarian tumors (s-BOT) with high intratumoral homogeneity. Int J Gynecol Pathol, 33(6), 592-597.
     
  233. Hohn AK, Einenkel J, Wittekind C, Horn LC (2014). [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer]. Pathologe, 35(4), 322-326.
     
  234. Horn LC, Einenkel J, Handzel R, Hohn AK (2014). [Morphology of secondary ovarian tumors and metastases]. Pathologe, 35(4), 336-347.
     
  235. Grothoff M, Piorkowski C, Eitel C, Gaspar T, Lehmkuhl L, Lucke C, Hoffmann J, Hildebrand L, Wedan S, Lloyd T, Sunnarborg D, Schnackenburg B, Hindricks G, Sommer P, Gutberlet M (2014). MR imaging-guided electrophysiological ablation studies in humans with passive catheter tracking: initial results. Radiology, 271(3), 695-702.
     
  236. Viehweger A, Riffert T, Dhital B, Knosche TR, Anwander A, Stepan H, Sorge I, Hirsch W (2014). The Gini coefficient: a methodological pilot study to assess fetal brain development employing postmortem diffusion MRI. Pediatr Radiol, 44(10), 1290-1301.
     
  237. Andreotti F, Riedl M, Himmelsbach T, Wedekind D, Wessel N, Stepan H, Schmieder C, Jank A, Malberg H, Zaunseder S (2014). Robust fetal ECG extraction and detection from abdominal leads. Physiol Meas, 35(8), 1551-1567.
     
  238. Schubert RA, Schleussner E, Hoffmann J, Fiedler A, Stepan H, Gottschlich A (2014). [Prevention of preterm birth by Shirodkar cerclage--clinical results of a retrospective analysis]. Z Geburtshilfe Neonatol, 218(4), 165-170.
     
  239. Ebert T, Stepan H, Schrey S, Kralisch S, Hindricks J, Hopf L, Platz M, Lossner U, Jessnitzer B, Drewlo S, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine, 65(2), 153-158.
     
  240. Höckel M (2014). (Laterally) Extended Endopelvic Resection, Chapter 9. In: Bristow RE, Chi D, Radical and Reconstructive Gynecologic Cancer Surgery. (S. 10), New York: McGraw-Hill.
     


  241. 2013


  242. Faber R, Risse S, Steinke H, Thome U, Stepan H (2013). Monochorionic quadruplet pregnancy without severe complications: sonographic workup and placental findings. Letter. Ultrasound Obstet Gynecol, 41(6), 707-708.
     
  243. Fischer M, Quaas M, Wintsche A, Muller GA, Engeland K (2013). Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein. Nucleic Acids Res, 42(1), 163-180.
     
  244. Fischer M, Grundke I, Sohr S, Quaas M, Hoffmann S, Knorck A, Gumhold C, Rother K (2013). p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes. PLoS One, 8(5), e63187.
     
  245. Chen X, Muller GA, Quaas M, Fischer M, Han N, Stutchbury B, Sharrocks AD, Engeland K (2013). The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol Cell Biol, 33(2), 227-236.
     
  246. Hockel M (2013). Does treatment progress follow the Cinderella principle? Gynecol Oncol, 129(1), 265-266.
     
  247. Hockel M, Horn LC (2013). The puzzle of close surgical margins is not puzzling. Gynecol Oncol, 130(1), 224-225.
     
  248. Horn LC, Kafkova S, Leonhardt K, Kellner C, Einenkel J (2013). Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas. Int J Gynecol Pathol, 32(4), 339-344.
     
  249. Stepan H, Kley K, Hindricks J, Kralisch S, Jank A, Schaarschmidt W, Schrey S, Ebert T, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Richter J, Fasshauer M (2013). Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine, 62(2), 322-326.
     
  250. Stepan H, Richter J, Kley K, Kralisch S, Jank A, Schaarschmidt W, Ebert T, Lossner U, Jessnitzer B, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2013). Serum levels of growth arrest specific protein 6 are increased in preeclampsia. Regul Pept, 182, 7-11.
     
  251. Schaarschmidt W, Rana S, Stepan H (2013). The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med, 41(5), 511-516.
     
  252. Briest S, Klein-Tebbe A (2013). Mammakarzinom: Screening, Diagnostik und Therapie. Gynäkol Geburtsmed und Gynäkol Endokrinol, 9(3), 266-283.
     
  253. Schrey S, Kingdom J, Baczyk D, Fitzgerald B, Keating S, Ryan G, Drewlo S (2013). Leptin is differentially expressed and epigenetically regulated across monochorionic twin placenta with discordant fetal growth. Mol Hum Reprod, 19(11), 764-772.
     
  254. Smitz J, Lunenfeld B, Alexander H, Nyboe Andersen A, Blockeel C, Broekmans F, Calhaz-Jorge C, Dracea L, Fleming R, Jenkins J, Platteau P, de Ziegler D (2013). Ovarian Stimulation from 1970 until 2011: a paradigm shift. Reprod Biomed Online, 26(5), 431-439.
     
  255. Fleming R, Broekmans F, Calhaz-Jorge C, Dracea L, Alexander H, Nyboe Andersen A, Blockeel C, Jenkins J, Lunenfeld B, Platteau P, Smitz J, de Ziegler D (2013). Can ani-Mullerian hormone levles be used to determine gonadotrophin dose and treatment protocol for controlled ovarian stimulation? Reprod Biomed, 26(5), 431-439.
     
  256. Stearns V, Jacobs LK, Fackler M, Tsangaris TN, Rudek MA, Higgins M, Lange J, Cheng Z, Slater SA, Jeter SC, Powers P, Briest S, Chao C, Yoshizawa C, Sugar E, Espinoza-Delgado I, Sukumar S, Gabrielson E (2013). Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Clin Cancer Res, 19(14), 4008-4016.
     
  257. Vollrath M, Zenger M, Singer S, Einenkel J, Hinz A (2013). The course of fatigue in patients with gynecologic and breast cancer. J Gynecol Oncol, 24(3), 280-286.
     
  258. Horn LC, Schreiter C, Canzler A, Leonhardt K, Einenkel J, Hentschel B (2013). CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling. Ann Diagn Pathol, 17(6), 531-535.
     
  259. Mayer A, Hockel M, Schlischewsky N, Schmidberger H, Horn LC, Vaupel P (2013). Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix. Br J Cancer, 108(2), 402-408.
     
  260. Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J, Jonas S, Konnopka A, Papsdorf K, Langanke D, Lobner M, Schiefke F, Stolzenburg JU, Weimann A, Wirtz H, Konig HH, Riedel-Heller S (2013). Co-morbid mental health conditions in cancer patients at working age - prevalence, risk profiles, and care uptake. Psychooncology, 22(10), 2291-2297.
     
  261. Ramirez Avila GM, Gapelyuk A, Marwan N, Walther T, Stepan H, Kurths J, Wessel N (2013). Classification of cardiovascular time series based on different coupling structures using recurrence networks analysis. Philos Trans A Math Phys Eng Sci, 371(1997), 20110623.
     
  262. Ramirez Avila GM, Gapelyuk A, Marwan N, Stepan H, Kurths J, Walther T, Wessel N (2013). Classifying healthy women and preeclamptic patients from cardiovascular data using recurrence and complex network methods. Auton Neurosci, 178(1), 103-110.
     
  263. Wilhelm M, Dahl E, Alexander H, Brahler E, Stobel-Richter Y (2013). Ethical attitudes of German specialists in reproductive medicine and legal regulation of preimplantation sex selection in Germany. PLoS One, 8(2), e56390.
     
  264. Wilhelm M, Dahl E, Alexander H, Brähler E, Stöbel-Richter Y (2013). Einstellungen deutscher Reproduktionsmediziner zur vorgeburtlichen Geschlechtswahl. In: Tschudin S, Maier B, Blitzer J, Ditz S, Rauchfuß M, Grenzen wahrnehmen - respektieren - überwinden. Beiträge der 2. Drei-Länder-Tagung der DGPFG e. V., SAPGG und ÖGPGG 2012 (S. 105-129), Frankfurt am Main: Mabuse-Verlag GmbH.
     


  265. 2012


  266. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2012). Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in preeclampsia. J Endocrinol Invest, 35(6), 562-5.
     
  267. Zimmermann G, Ackermann W, Alexander H (2012). Expression and Production of Human Chorionic Gonadotropin (hCG) in the Normal Secretory Endometrium: Evidence of CGB7 and/or CGB6 Beta hCG Subunit Gene Expression. Biol Reprod, 86(3), e87.
     
  268. Hockel M, Horn LC, Einenkel J (2012). Laterally extended parametrectomy in nodal positive early stage cervical cancer: Right direction, wrong track. Gynecol Oncol, 125(3), 765-6.
     
  269. Hockel M, Horn LC, Tetsch E, Einenkel J (2012). Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy. Gynecol Oncol, 125(1), 168-74.
     
  270. Muller GA, Hansen U, Xu Z, Griswold B, Talan MI, McDonnell NB, Briest W (2012). Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts. FASEB J, 26(2), 668-677.
     
  271. Muller GA, Quaas M, Schumann M, Krause E, Padi M, Fischer M, Litovchick L, DeCaprio JA, Engeland K (2012). The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucleic Acids Res, 40(4), 1561-1578.
     
  272. Quaas M, Muller GA, Engeland K (2012). p53 can repress transcription of cell cycle genes through a p21 (WAF1/CIP1) -dependent switch from MMB to DREAM protein complex binding at CHR promoter elements. Cell Cycle, 11(24), 4661-4672.
     
  273. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H (2012). The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol, 206(1), e1-8.
     
  274. Jank A, Kratzsch J, Stepan H (2012). Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy, 31(2), 201-206.
     
  275. Tallarek AC, Stepan H (2012). [Preeclampsia and HELLP syndrome as an obstetric emergency]. Med Klin Intensivmed Notfmed, 107(2), 96-100.
     
  276. Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H (2012). The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem, 58(5), 837-845.
     
  277. Schrey S, Huber A, Hecher K, Quintero R, Alkazaleh F, Moise KJ Jr, Allbert JR, Schneider C, Palermo M, Yinon Y, Chmait RH, Windrim R, Ryan G (2012). Vascular limb occlusion in twin-twin transfusion syndrome (TTTS): case series and literature review. Am J Obstet Gynecol, 207(2), 131.
     
  278. Schrey S, Kelly EN, Langer JC, Davies GA, Windrim R, Seaward PG, Ryan G (2012). Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung. Ultrasound Obstet Gynecol, 39(5), 515-520.
     
  279. Tallarek AC, Stepan H (2012). HELLP-Syndrom - klinisches Chamäleon und geburtshilflicher Notfall. Geburtshilfe und Frauenheilkunde, 72(1), 27-29.
     
  280. Stepan H (2012). Behandlung der Präeklampsie - mithilfe der Blutwäsche. Geburtshilfe und Frauenheilkunde, 72, 580-582.
     
  281. Tallarek AC, Huppertz B, Stepan H (2012). Präeklampsie - Ätiologie, aktuelle Diagnostik und klinisches Management, neue Therapieoptionen und Zukunftsaussichten. Geburtshilfe und Frauenheilkunde, 72(12), 1107-1116.
     
  282. Hockel M, Horn LC (2012). Three-dimensional classification of radical hysterectomy: new saddle for an old horse. Gynecol Oncol, 124(1), 173-4.
     
  283. Hockel M, Einenkel J, Horn LC (2012). Paraaortic lymphatic spread in cervical cancer. Gynecol Oncol, 127(3), 677.
     
  284. Hockel M, Horn LC, Einenkel J (2012). (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol, 127(2), 297-302.
     
  285. Höckel M (2012). Comment on: Laterally extended parametrectomy. Gynecol Oncol, 125(3), 767.
     
  286. Horn LC, Kellner C, Scherling R, Hockel M, Einenkel J (2012). Ultrastaging for micrometastases in para-aortic lymph nodes in patients with carcinoma of the uterine cervix. Gynecol Oncol, 124(2), 374-5.
     
  287. Hockel M (2012). Cancer permeates locally within ontogenetic compartments: clinical evidence and implications for cancer surgery. Future Oncol, 8(1), 29-36.
     
  288. Einenkel J, Braumann UD, Steller W, Binder H, Horn LC (2012). Suitability of infrared microspectroscopic imaging for histopathology of the uterine cervix. Histopathology, 60(7), 1084-1098.
     
  289. Horn LC, Hommel N, Roschlau U, Bilek K, Hentschel B, Einenkel J (2012). Peritumoral stromal remodeling, pattern of invasion and expression of c-met/HGF in advanced squamous cell carcinoma of the cervix uteri, FIGO stages III and IV. Eur J Obstet Gynecol Reprod Biol, 163(1), 76-80.
     
  290. Höckel M (2012). Ontogenetische Anatomie. Grundlage für neue Operationen zur Behandlung gynäkologischer Krebserkrankungen. Gynäkol Prax, 36, 409-420.
     
  291. Muller G, Tarasov KV, Gundry RL, Boheler KR (2012). Human ESC/iPSC-based "Omics" and Bioinformatics for Translational Research. Drug Discov Today Dis Models, 9(4), e161-170.
     
  292. Singer S, Krauß O, Keszte J, Siegl G, Papsdorf K, Severi E, Hauss J, Briest S, Dietz A, Brähler E, Kortmann RD (2012). Predictors of emotional distress in patients with head and neck cancer. Head Neck, 34(2), 180-7.
     
  293. Gartner C, Ziegelhoffer B, Kostelka M, Stepan H, Mohr FW, Dhein S (2012). Knock-down of endothelial connexins impairs angiogenesis. Pharmacol Res, 65(3), 347-57.
     
  294. Ueberschär O, Krüger M, Gutsche C, Stangner T, Wagner C, Kühne K, Kremer F (2012). Microfluidic mobility of single (DNA-grafted) colloids in dilute DNA suspensions. Polymer, 53(25), 5760-5770.
     
  295. Schwalenberg T, Stolzenburg JU, Ho TP, Mallock T, Hartenstein S, Alexander H, Zimmermann G, Hohenfellner R, Denzinger S, Burger M, Horn LC, Neuhaus J (2012). Enhanced urothelial expression of human chorionic gonadotropin beta (hCGß) in bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol, 30(3), 411-417.
     
  296. Dukic-Stefanovic S, Walther J, Wosch S, Zimmermann G, Wiedemann P, Alexander H, Claudepierre T (2012). Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions. PLoS One, 7(12), e52567.
     
  297. Richter R, Oskay-Oezcelik G, Chekerov R, Pilger A, Hindenburg HJ, Sommer H, Camara O, Keil E, Einenkel J, Sehouli J (2012). Health-related quality of life during sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: a multicenter phase ii study of the North Eastern German Society of Gynecological Oncology. Anticancer Res, 32(9), 3969-3976.
     
  298. Hinz A, Einenkel J, Briest S, Stolzenburg JU, Papsdorf K, Singer S (2012). Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30? Eur J Cancer Care (Engl), 21(5), 677-683.
     
  299. Pecks U, Schutt A, Rower C, Reimer T, Schmidt M, Preschany S, Stepan H, Rath W, Glocker MO (2012). A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder. Hypertens Pregnancy, 31(2), 278-291.
     
  300. Nickisch S, Kratzsch J, Gebauer C, Waldeyer T, Stepan H, Kiess W (2012). Glucose tolerance in women 24 h postpartum is related to blood pressure, anthropometric data, and adipokine serum levels. Hypertens Pregnancy, 31(2), 228-239.
     
  301. Verlohren S, Stepan H, Dechend R (2012). Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond), 122(2), 43-52.
     
  302. Miehle K, Stepan H, Fasshauer M (2012). Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf), 76(1), 2-11.
     
  303. Duerrschmidt N, Hagen A, Gaertner C, Wermke A, Nowicki M, Spanel-Borowski K, Stepan H, Mohr FW, Dhein S (2012). Nicotine effects on human endothelial intercellular communication via α4β2 and α3β2 nicotinic acetylcholine receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol, 385(6), 621-632.
     
  304. Wilhelm M, Hirsch W, Merkenschlager A, Stepan H, Geyer C, Kiess W (2012). A rare case of congenital choroid plexus carcinoma. Pediatr Hematol Oncol, 29(7), 643-646.
     
  305. Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, Ditsch N, Janni W, Mundhenke C, Golatta M, Varga D, Preisler-Adams S, Heinrich T, Bick U, Gadzicki D, Briest S, Meindl A, Schmutzler RK (2012). The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res, 14(6), R156.
     
  306. Voelker A, Hoeckel M, Heyde CE (2012). Lumbosacral spondylodiscitis after sacral colpopexy of a sigmoid neovagina in a patient with vaginal melanoma. Surg Infect (Larchmt), 13(2), 134-135.
     
  307. Stepan H, Faber R, Heling KS, Hirsch W, Jank A, Sorge I (2012). Innovative Diagnostik in der Geburtsmedizin. In: Stepan H, Innovative Diagnostik in der Geburtsmedizin. (S. 1-89), Bremen: UNI-MED.
     


  308. 2011


  309. Bohlig L, Friedrich M, Engeland K (2011). p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res, 39(2), 440-453.
     
  310. Rüger R, Horn LC, Helbig D, Simon J, Wetzig T, Briest S (2011). [Perimamillar located ulcerous skin lesion in a 75-year old patient]. J Dtsch Dermatol Ges, 9(2), 162–166.
     
  311. Bohlig L, Rother K (2011). One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor. J Biomed Biotechnol, 2011, e464916.
     
  312. Sohr S, Engeland K (2011). The tumor suppressor p53 induces expression of the pregnancy-supporting human chorionic gonadotropin (hCG) CGB7 gene. Cell Cycle, 10(21), 3758-3767.
     
  313. Hockel M, Horn LC (2011). Cervical cancer: balancing obstetrical and oncological outcomes. Lancet Oncol, 12(5), 422.
     
  314. Einenkel J, Handzel R (2011). Surgical removal of a gigantic abdominal mass: a multidisciplinary approach. Obstet Gynecol, 118(3), 710-710.
     
  315. Hockel M, Horn LC, Illig R, Dornhofer N, Fritsch H (2011). Ontogenetic anatomy of the distal vagina: relevance for local tumor spread and implications for cancer surgery. Gynecol Oncol, 122(2), 313-318.
     
  316. Einenkel J, Holler B, Hoffmeister A (2011). Sonographic diagnosis and Endo-SPONGE assisted vacuum therapy of anastomotic leakage following posterior pelvic exenteration for ovarian cancer without using a protective stoma. J Gynecol Oncol, 22(2), 131-134.
     
  317. Ruger RD, Horn LC, Helbig D, Simon JC, Wetzig T, Briest S (2011). [Perimamillar located ulcerous skin lesion in a 75-year old patient]. J Dtsch Dermatol Ges, 9(2), 162-166.
     
  318. Horn LC, Einenkel J (2011). Uterine perivascular epitheloid cell tumor (PEComa) with CD117 and PNL2 positivity and entrapped endometriotic glands, mimicking sex-cordlike differentiation. Ann Diagn Pathol, 15(3), 216-218.
     
  319. Horn LC, Klostermann K (2011). [Precancerous lesions of the uterine cervix: morphology and molecular pathology]. Pathologe, 32(Suppl2), 242-254.
     
  320. Horn LC, Teichmann G, Einenkel J (2011). Das PECom des Uterus - ein seltener mesenchymaler Tumor: Fallbericht und Literaturübersicht. Geburtsh Frauenheilk, 71(2), 140-143.
     
  321. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept, 168(1-3), 69-72.
     
  322. Jank A, Schaarschmidt W, Stepan H (2011). Effect of steroids on angiogenic factors in pregnant women with HELLP syndrome. J Perinat Med, 39(5), 611-613.
     
  323. Petzold K, Jank A, Faber R, Stepan H (2011). Relation between maternal angiogenic factors and utero-placental resistance in normal first- and second-trimester pregnancies. Hypertens Pregnancy, 30(4), 401-407.
     
  324. Bette S, Unger T, Lakowa N, Friedrich M, Engele J (2011). Sequences of the non-coding RNA, NTAB, are contained within the 3'-UTR of human and rat EAAT2/GLT-1 transcripts and act as transcriptional enhancers. Cell Mol Neurobiol, 31(3), 393-399.
     
  325. Singer S, Kuhnt S, Zwerenz R, Eckert K, Hofmeister D, Dietz A, Giesinger J, Hauss J, Papsdorf K, Briest S, Brown A (2011). Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer, 105(3), 445-451.
     
  326. Singer S, Brown A, Einenkel J, Hauss J, Hinz A, Klein A, Papsdorf K, Stolzenburg JU, Brahler E (2011). Identifying tumor patients' depression. Support Care Cancer, 19(11), 1697-1703.
     
  327. Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC (2011). p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol, 30(5), 417-424.
     
  328. Ueberschär O, Wagner C, Stangner T, Kühne K, Gutsche C, Kremer F (2011). Drag reduction by DNA-grafting for single microspheres in a dilute lambda-DNA solution. Polymer, 52(18), 4021-4032.
     
  329. Engeland CE, Oberwinkler H, Schumann M, Krause E, Muller GA, Krausslich HG (2011). The cellular protein lyric interacts with HIV-1 Gag. J Virol, 85(24), 13322-13332.
     
  330. Mayer A, Hockel M, Horn LC, Schmidberger H, Vaupel P (2011). GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion. Int J Oncol, 38(1), 145-150.
     
  331. Vaupel P, Hoeckel M, Mayer A (2011). Oxygenation status of urogenital tumors. Adv Exp Med Biol, 701, 101-106.
     
  332. Horn LC, Klostermann K, Hautmann S, Hohn AK, Beckmann MW, Mehlhorn G (2011). [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology]. Pathologe, 32(6), 467-475.
     
  333. Richter D, Geue K, Matthes A, Berberich HJ, Alexander H, Strauss B, Brahler E (2011). [Fertility and cancer--outlining of the issue]. Psychother Psychosom Med Psychol, 61(6), 246-253.
     
  334. Neuhaus J, Schwalenberg T, Horn LC, Alexander H, Stolzenburg JU (2011). New aspects in the differential diagnosis and therapy of bladder pain syndrome/interstitial cystitis. Adv Urol, 2011, e639479.
     
  335. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing (2011). Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation, 124(8), 940-950.
     
  336. Zenger M, Glaesmer H, Hockel M, Hinz A (2011). Pessimism predicts anxiety, depression and quality of life in female cancer patients. Jpn J Clin Oncol, 41(1), 87-94.
     
  337. Einenkel J (2011). Techniques of diaphragmatic surgery. In: Ayhan A, Reed N, Gultekin M, Dursun P, Textbook of gynaecological oncology. (S. 721-729), Ankara: Günes Publishing.
     


  338. 2010


  339. Muller GA, Engeland K (2010). The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription. FEBS J, 277(4), 877 - 893.
     
  340. Stepan H, Kralisch S, Klostermann K, Schrey S, Reisenbuchler C, Verlohren M, Verlohren HJ, Drynda K, Bluher M, Stumvoll M, Kratzsch J, Kovacs P, Fasshauer M (2010). Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism, 59(7), 1054-1056.
     
  341. Stepan H, Philipp A, Reiche M, Klostermann K, Schrey S, Reisenbüchler C, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M (2010). Serum levels of the adipokine lipocalin-2 are increased in preeclampsia. J Endocrinol Invest, 33(9), 629-632.
     
  342. Horn LC, Hentschel B, Einenkel J (2010). Topographic distribution of pelvic lymph node metastases in cervical cancer patients with FIGO stages IB1 to IIB [Cibula D, Abu-Rustum NR. Pelvic lymphadenectomy in cervical cancer--surgical anatomy and proposal for a new classification system. Gynecol Oncol, 118(1), 93-4.
     
  343. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H (2010). An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol, 202(2), 161e1-e11.
     
  344. Hockel M (2010). [Oncological pelvic surgery from a gynecological perspective]. Chirurg, 81(10), 875-882.
     
  345. Hockel M, Kahn T, Einenkel J, Manthey N, Braumann UD, Hildebrandt G, Leo C, Hentschel B, Vaupel P, Horn LC (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecol Oncol, 117(3), 401-408.
     
  346. Hockel M, Schmidt K, Bornmann K, Horn LC, Dornhofer N (2010). Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol Oncol, 119(1), 106-113.
     
  347. Marais A, Ji Z, Child ES, Krause E, Mann DJ, Sharrocks AD (2010). Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK·cyclin complexes. J Biol Chem, 285(46), 35728-35739.
     
  348. Kirschner RD, Rother K, Muller GA, Engeland K (2010). The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes. Cell Cycle, 9(11), 2177-2188.
     
  349. Horn LC, Trost M, Bilek K (2010). Staging of endometrial carcinoma: aspects of ovarian and cervical involvement. Int J Gynecol Pathol, 29(1), 63-66.
     
  350. Mayer S, Till H, Stepan H (2010). EXIT procedure in a neonate with a prenatally diagnosed granular cell tumor. Pediatr Surg Int, 26(9), 935-937.
     
  351. Lapaire O, Shennan A, Stepan H (2010). The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol, 151(2), 122-129.
     
  352. Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J (2010). [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience]. Z Geburtshilfe Neonatol, 214(6), 234-238.
     
  353. Singer S, Kuhnt S, Momenghalibaf A, Stuhr C, Dimmel-Hennersdorf U, Kohler U, Einenkel J (2010). Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery. Gynecol Oncol, 116(1), 82-87.
     
  354. Einenkel J, Wuttke P, Horn K (2010). Should the extreme drug resistance assay fade into oblivion? Commentary on Karam, A.K., Chiang, J.W., Fung, E., Nossov, V. and Karlan, B.Y. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer. Gynecol Oncol. 2009;114:246-252. Gynecol Oncol, 116(1), 148-9.
     
  355. Einenkel J, Handzel R, Horn LC (2010). Persisting pregnancy of unknown location--keep your eyes peeled for choriocarcinoma. Eur J Obstet Gynecol Reprod Biol, 153(2), 229-231.
     
  356. Oskay-Ozcelik G, Chekerov R, Sommer H, Keil E, Einenkel J, Pfisterer J, Lorenz-Schluter C, Lichtenegger W, Camara O, Sehouli J (2010). Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: Results of a multicenter phase II study of the northeastern German society of gynecological oncology. Gynecol Oncol, 116(3), 317-322 .
     
  357. Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism, 59(1), 33-37.
     
  358. Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, Schwarz R (2010). Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl), 19/4), 522-529.
     
  359. Mayer A, Hoeckel M, von Wallbrunn A, Horn LC, Wree A, Vaupel P (2010). HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas. Adv Exp Med Biol, 662, 399-405.
     
  360. Vaupel P, Kelleher DK, Hoeckel M (2010). Tumor hypoxia as a function of hemoglobin concentration and tumor perfusion. Int J Radiat Oncol Biol Phys, 76(3), 958-9.
     
  361. Fritsch A, Höckel M, Kiesslin T, Kenechukwu DN, Wetzel F, Zink M, Käs JA (2010). Are biochemical changes necessary for tumour progession. Nature Phys, 6(10), 730-732.
     
  362. Cooper TK, Zhong Q, Krawczyk M, Tae HJ, Muller GA, Schubert R, Myers LA, Dietz HC, Talan MI, Briest W (2010). The haploinsufficient col3a1 mouse as a model for vascular ehlers-danlos syndrome. Vet Pathol, 47(6), 1028-1039.
     
  363. Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr, 74(1), 56-61.
     
  364. Riedl M, Suhrbier A, Stepan H, Kurths J, Wessel N (2010). Short-term couplings of the cardiovascular system in pregnant women suffering from pre-eclampsia. Philos Transact A Math Phys Eng Sci, 368(1918), 2237-2250.
     
  365. Schwalenberg T, Neuhaus J, Horn LC, Alexander H, Zimmermann G, Ho Thi P, Mallock T, Stolzenburg JU (2010). [New insights in the differential diagnosis of bladder pain syndrome]. Aktuelle Urol, 41(2), 107-118.
     
  366. Richter D, Geue K, Matthes A, Berberich HJ, Alexander H, Strauss B, Brahler E (2010). Fertility and Cancer - Outlining of the Issue. Psychother Psychosom Med Psychol, 61(6), 246-253.
     
  367. Schwalenberg T, Neuhaus J, Alexander H, Zimmermann G, Horn LC, Stolzenburg JU (2010). Frühe Diagnose und kausale Therapie anstreben. Gynäkologie und Geburtshilfe, 12, 22-28.
     
  368. Briest S, Stearns V (2010). Neoadjuvant Therapy. In: Jacobs L , Finlayson C, Early Diagnosis of Cancer: Breast Cancer. (S. 261-279), Philadelphia: Saunders Elsevier.
     
  369. Stepan H (2010). Physiologie des mütterlichen Organismus und Anpassungsvorgänge in der Schwangerschaft. In: Rath W, Gembruch U, Schmidt S, Geburtshilfe und Perinatalmedizin. (S. 21-31), Stuttgart: Thieme Verlag.
     


  370. 2009


  371. Hockel M, Dornhofer N (2009). Treatment of early endometrial carcinoma: is less more? Lancet, 373(9658), 97-99.
     
  372. Stepan H, Ebert T, Schrey S, Reisenbuchler C, Stein S, Lossner U, Bluher M, Stumvoll M, Kratzsch J, Faber R, Fasshauer M (2009). Serum Levels of Angiopoietin-Related Growth Factor Are Increased in Preeclampsia. Am J Hypertens, 22(3), 314-318.
     
  373. Stepan H (2009). Angiogenic factors and pre-eclampsia: an early marker is needed. Clin Sci (Lond), 116(3), 231-232.
     
  374. Stepan H, Ebert T, Schrey S, Reisenbüchler C, Stein S, Blüher M, Stumvoll M, Kratzsch J, Tönnessen P, Faber R, Fasshauer M (2009). Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia. Metabolism, 58(3), 275-277.
     
  375. Briest S, Winkelmann C, Meyer A, Froster UG (2009). Brustkrebs. Patientenbroschüre. Sächsische Krebsgesellschaft, 10, 1-62.
     
  376. Hockel M, Horn LC, Manthey N, Braumann UD, Wolf U, Teichmann G, Frauenschlager K, Dornhofer N, Einenkel J (2009). Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol, 10(7), 683-692.
     
  377. Hockel M, Dornhofer N (2009). Understanding and preventing local tumour recurrence. Lancet Oncol, 10(7), 645-646.
     
  378. Hockel M (2009). Principles and practice of surgical treatment for cervical cancer: it\'s time for a change. Womens Health (Lond Engl), 5(5), 459-462.
     
  379. Höckel M (2009). Die Kompartimentresektion des Zervixkarzinoms. Gynäkologe, 42(12), 932-936.
     
  380. Einenkel J, Handzel R (2009). Diaphragm surgery. Int J Gynecol Cancer, 19(4), 811.
     
  381. Einenkel J, Ott R, Handzel R, Braumann UD, Horn LC (2009). Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer. Int J Gynecol Cancer, 19(7), 1288-1297.
     
  382. Briest S, Stearns V (2009). Tamoxifen metabolism and its effect on endocrine treatment of breast cancer. Clin Adv Hematol Oncol, 7(3), 185-192.
     
  383. Zimmermann G, Ackermann W, Alexander H (2009). Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle. Biol Reprod, 80(5), 1053-1065.
     
  384. Briest S, Vang R, Terrell K, Emens L, Lange J-R (2009). Invasive lobular carcinoma of the male breast: a rare histology in an uncommon disease. Breast care, 4(1), 36-38.
     
  385. Stepan H, Jank A (2009). [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia] Z Geburtshilfe Neonatol, 213(3), 101-105.
     
  386. Stepan H (2009). Mütterliche Langzeitmorbidität nach Präeklampsie erhöht. Frauenarzt, 50(4), 328-335.
     
  387. Klostermann K, Stepan H (2009). Bildzitat: Variköse Cervix uteri bei Placenta percreta. Frauenarzt, 50(5), 440.
     
  388. Horn LC, Dallacker M, Bilek K (2009). [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors] Pathologe, 30(4), 292-301.
     
  389. Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol, 160(1), 33-38.
     
  390. Ehrhardt N, Kujat A, Faber R, Horn LC, Froster UG (2009). Potential errors with rapid analysis techniques: partial duplication 21q resulting from a paternal paracentric insertion uncovered in chorionic villus sampling by fluorescence in situ hybridization. Fetal Diagn Ther, 26(4), 219-222.
     
  391. Horn LC, Einenkel J, Vogel M (2009). [Histopathology of gestational trophoblastic disease. An update] Pathologe, 30(4), 313-323.
     
  392. Olkhanud PB, Baatar D, Bodogai M, Hakim F, Gress R, Anderson RL, Deng J, Xu M, Briest S, Biragyn A (2009). Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res, 69(14), 5996-6004.
     
  393. Winkelmann C, Briest S (2009). Leitlinie Mammakarzinom: Diagnostik, Therapie und Nachsorge des Mammakarzinoms im Kontext der akut- stationären Physiotherapie in Deutschland. Z Physiother, 61(1), 41-45.
     
  394. Winkelmann C, Briest S, Riedel-Heller S (2009). Leitlinie für die Rehabilitation nach Mammakarzinom. Z Physiother, 61(3), 261-265.
     
  395. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A, Malfertheiner SF, Costa SD, Zimmermann G, Nitschke C, Volk HD, Alexander H, Gunzer M, Zenclussen AC (2009). Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol, 182(9), 5488-5497.
     
  396. Sommer G, Kralisch S, Stangl V, Vietzke A, Kohler U, Stepan H, Faber R, Schubert A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem, 106(4), 729-737.
     
  397. Koelsch S, Wiebigke C, Siebel WA, Stepan H (2009). Impulsive aggressiveness of pregnant women affects the development of the fetal heart. Int J Psychophysiol, 74(3), 243-249.
     
  398. Unger S, Weigel JF, Stepan H, Baerwald CG (2009). A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr, 159(19-20), 507-510.
     
  399. Horn LC, Hentschel B, Meinel A, Alexander H, Leo C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Ann Diagn Pathol, 13(6), 373-377.
     
  400. Mühler K, Pulzer F, Robel-Tillig E, Knüpfer M, Gebauer C, Keller A, Nickel P, Stepan H, Till H, Kiess W (2009). Case-Management in der psychosozialen Begleitung von Eltern Frühgeborener und kranker Neugeborener. Kinder- und Jugendmedizin, 9(2), 71-72.
     
  401. Emons G, Kimmig R (2009). Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma. J Cancer Res Clin Oncol, 135(10), 1387-1391.
     
  402. Horn LC, Schierle K, Klostermann K, Schnurch HG, Hantschmann P (2009). [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva] Pathologe, 30(1), 56-64.
     
  403. Singer S, Gotze H, Mobius C, Witzigmann H, Kortmann RD, Lehmann A, Hockel M, Schwarz R, Hauss J (2009). Quality of care and emotional support from the inpatient cancer patient\'s perspective. Langenbecks Arch Surg, 394(4), 723-731.
     
  404. Briest S, Wolff AC (2009). Breast Cancer. In: Ettinger DS, Donehower RC, Schwartz RN, Olsen M, Current Cancer Therapeutics. (S. 77-90), Philadelphia: Springer Verlag.
     


  405. 2008


  406. Einenkel J, Braumann UD, Horn LC (2008). In response to N.N. Mahajan, R.N. Soni, N.L. Gaikwad, K.N. Mahajan: Giant ovarian cysts: is a pre- and intraoperative drainage an advisable procedure? Int J Gynecol Cancer, 18(1), 206-207.
     
  407. Horn LC, Hentschel B, Galle D, Bilek K (2008). Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri. Gynecol Oncol, 108(1), 63-67.
     
  408. Horn LC, Purz S, Krumpe C, Bilek K (2008). COX-2 and Her-2/neu are overexpressed in Paget\'s disease of the vulva and the breast: results of a preliminary study. Arch Gynecol Obstet, 277(2), 135-138.
     
  409. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine visfatin are increased in preeclampsia. Clin Endocrinol, 69(1), 69-73.
     
  410. Gembardt F, Heringer-Walther S, van Esch JH, Sterner-Kock A, van Veghel R, Le TH, Garrelds IM, Coffman TM, Danser AH, Schultheiss HP, Walther T (2008). Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J, 22(8), 3068-3077.
     
  411. Horn LC, Meinel A, Handzel R, Einenkel J (2008). Authors' reply to Zheng and Chambers in Annals of Diagnostic Pathology. Ann Diagn Pathol, 12(3), 232-233.
     
  412. Ebermann L, Spillmann F, Sidiropoulos M, Escher F, Heringer-Walther S, Schultheiss HP, Tschope C, Walther T (2008). The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats. Eur J Pharmacol, 590(1-3), 276-280.
     
  413. Horn LC, Purz S, Leo C, Stepan H (2008). Application of tissue microarrays in placental research. Ann Diagn Pathol, 12(1), 48-49.
     
  414. Walther T, Jank A, Heringer-Walther S, Horn LC, Stepan H (2008). Angiotensin II type 1 receptor has impact on murine placentation. Placenta, 29(10), 905-909.
     
  415. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens, 26(9), 1824-1828.
     
  416. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens, 21(5), 582-586.
     
  417. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol, 158(2), 197-201.
     
  418. Stepan H, Geipel A, Schwarz F, Kramer T, Wessel N, Faber R (2008). Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol, 198(2), 175.e1-6.
     
  419. Bohlig L, Metzger R, Rother K, Till H, Engeland K (2008). The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor. Cell Cycle, 7(9), 1254-1261.
     
  420. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf), 69(1), 69-73.
     
  421. Friedrich M, Böhlig L, Kirschner RD, Engeland K, Hauschildt S (2008). Identification of two regulatory binding sites which confer myotube specific expression of the mono-ADP-ribosyltransferase ART1 gene. BMC Mol Biol, 9, 91 ff.
     
  422. Dornhofer N, Hockel M (2008). New developments in the surgical therapy of cervical carcinoma. Ann N Y Acad Sci, 1138, 233-252.
     
  423. Hockel M (2008). Laterally extended endopelvic resection (LEER)--principles and practice. Gynecol Oncol, 111(Suppl 2), S13-S17.
     
  424. Hockel M, Dornhofer N (2008). Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol, 9(6), 559-568.
     
  425. Horn LC, Liebert UG, Edelmann J, Hockel M, Einenkel J (2008). Adenoid squamous carcinoma (pseudoangiosarcomatous carcinoma) of the vulva: a rare but highly aggressive variant of squamous cell carcinoma-report of a case and review of the literature. Int J Gynecol Pathol, 27(2), 288-291.
     
  426. Einenkel J, Handzel R (2008). Surgical management of giant ovarian tumors. J Obstet Gynaecol Res, 34(1), 125.
     
  427. Kirschner RD, Sanger K, Muller GA, Engeland K (2008). Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. Nucleic Acids Res, 36(9), 2969-2980.
     
  428. Sohr S, Engeland K (2008). RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53. Cell Cycle, 7(21), 3448-3460.
     
  429. Horn LC, Hentschel B, Fischer U, Peter D, Bilek K (2008). Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact. Gynecol Oncol, 111(2), 276-281.
     
  430. Briest S, Stearns V (2008). Adjuvant aromatase inhibitors and emerging quality-of-life considerations. Expert Rev Anticancer Ther, 8(1), 1-4.
     
  431. Moreira Mda C, Heringer-Walther S, Wessel N, Moreira Ventura T, Wang Y, Schultheiss HP, Walther T (2008). Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Cardiology, 110(4), 217-225.
     
  432. Thiel F, Horn LC, Jud S, Beckmann MW, Einenkel J (2008). Gestationsbedingte Trophoblasterkrankungen. Frauenheilkunde up2date, 2(4), 327-345.
     
  433. Hockel M (2008). Totale mesometriale Resektion (TMMR). Gynäkologe, 41(5), 361-368.
     
  434. Dornhöfer N, Stepan H (2008). Preeclampsia - more than a pregnancy complication Human Ontogenetics, 2, 29-38.
     
  435. Dornhöfer N, Baier D, Faber R, Stepan H (2008). Uterusverletzung mit Folgen Gynäkologe, 41(10), 830-832.
     
  436. Buchbinder S, Kratzsch J, Fiedler GM, Yar V, Brügel M, Leichtle A, Weber W, Alexander H, Matthes G, Thiery J (2008). Body weight and oral contraceptives are the most important modulators of serum CRP levels. Scand J Clin Lab Invest, 68(2), 140-144.
     
  437. Kralisch S, Sommer G, Stangl V, Köhler U, Kratzsch J, Stepan H, Faber R, Schubert A, Lössner U, Vietzke A, Bluher M, Stumvoll M, Fasshauer M (2008). Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis, 196(2), 523-531.
     
  438. Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, Salata R, Arts EJ (2008). Molecular Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of Major Drug Resistance Mutations in Newly Diagnosed Patients Infected with Subtypes Other than Subtype B. J Clin Microbiol, 46(1), 177-184.
     
  439. Metzger R, Neugebauer A, Rolle U, Bohlig L, Till H (2008). C-Kit receptor (CD117) in the porcine urinary tract. Pediatr Surg Int, 24(1), 67-76.
     
  440. Mayer A, Hockel M, Wree A, Leo C, Horn LC, Vaupel P (2008). Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res, 68(12), 4719-4726.
     
  441. Rotzoll DE, Scherling R, Etzl R, Stepan H, Horn LC, Poschl JM (2008). Immunohistochemical localization of alpha-tocopherol transfer protein and lipoperoxidation products in human first-trimester and term placenta. Eur J Obstet Gynecol Reprod Biol, 140(2), 183-191.
     
  442. Schwarz R, Krauss O, Höckel M, Meyer A, Zenger M, Hinz A (2008). The course of anxiety and depression in patients with breast cancer and gynaecological cancer. Breast Care, 3(6), 417-422.
     
  443. Hermes M, Schormann W, Brulport M, Uhlemann K, Lupatsch F, Horn LC, Schumann A, Allgaier C, Weishaupt M, Engeland K, Muller GA, Mossner J, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Lausch E, Prawitt (2008). Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model. Brit J Cancer, 98(9), 1525-1532.
     
  444. Heinritz W, Strenge S, Kujat A, Hockel M, Froster UG (2008). Different phenotypes including gynecological cancer in three female patients with Peutz-Jeghers syndrome and mutations in the STK11 gene. Onkologie, 31(11), 625-628.
     
  445. Bringmann H, Singer S, Hockel M, Stolzenburg JU, Krauss O, Schwarz R (2008). Longitudinal analysis of psychiatric morbidity in cancer patients. Onkologie, 31(6), 343-344.
     
  446. Mayer A, Höckel M, Vaupel P (2008). Endogenous hypoxia markers: case not proven! Adv Exp Med Biol, 614, 127-136.
     
  447. Nehls K, Vinokurova S, Schmidt D, Kommoss F, Reuschenbach M, Kisseljov F, Einenkel J, von Knebel Doeberitz M, Wentzensen N (2008). p16 methylation does not affect protein expression in cervical carcinogenesis. Eur J Cancer, 44(16), 2496-2505.
     
  448. Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz MK, Wentzensen N (2008). Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer, 123(11), 2626-2631.
     
  449. Rolle U, Faber R, Robel-Tillig E, Muensterer O, Hirsch W, Till H (2008). Bladder outlet obstruction causes fetal enterolithiasis in anorectal malformation with rectourinary fistula. J Pediatr Surg, 43(4), 11-13.
     
  450. Schastak S, Gitter B, Handzel R, Hermann R, Wiedemann P (2008). Improved photoinactivation of gram-negative and gram-positive methicillin-resistant bacterial strains using a new near-infrared absorbing meso-tetrahydroporphyrin: a comparative study with a chlorine e6 photosensitizer photolon. Methods Find Exp Clin Pharmacol, 30(2), 129-133.
     
  451. Bringmann H, Singer S, Höckel M, Stolzenburg J-U, Krauss O, Schwarz R (2008). Long-term course of psychiatric disorders in cancer patients: a pilot study. GMS Psycho-Social-Medicine, 5, 1-9.
     
  452. Beckmann MW, Einenkel J, Thiel F, Horn LC (2008). Gestationelle und nicht-gestationelle Trophoblasterkrankungen. Frauenarzt, 49(4), 356-360.
     
  453. Stepan H (2008). Mutter und Kind im Wochenbett. In: Kiechle M, Repetitorium Gynäkologie und Geburtshilfe. (S. 176-188), München: Urban & Fischer Verlag.
     


  454. 2007


  455. Stepan H, Wallukat G, Schultheiss HP, Faber R, Walther T (2007). Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? J Reprod Immunol, 73(2), 130-134.
     
  456. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H (2007). Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf), 66(3), 434-439.
     
  457. Leo C, Horn LC, Rauscher C, Hentschel B, Richter CE, Schutz A, Leo CP, Hockel M (2007). Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer. Clin Cancer Res, 13(4), 1149-1153.
     
  458. Einenkel J, Braumann UD, Horn LC, Pannicke N, Kuska JP, Schutz A, Hentschel B, Hockel M (2007). Evaluation of the invasion front pattern of squamous cell cervical carcinoma by measuring classical and discrete compactness. Comput Med Imaging Graph, 31(6), 428-435.
     
  459. Leo C, Horn LC, Einenkel J, Hentschel B, Hockel M (2007). Tumor hypoxia and expression of c-met in cervical cancer. Gynecol Oncol, 104(1), 181-185.
     
  460. Einenkel J, Braumann UD, Horn LC, Kuska JP, Hockel M (2007). 3-D analysis of the invasion front in squamous cell carcinoma of the uterine cervix: histopathologic evidence for collective invasion per continuitatem. Anal Quant Cytol Histol, 29(5), 279-290.
     
  461. Hockel M (2007). Insights into incomplete excision. Lancet Oncol, 8(11), 957-959.
     
  462. Hockel M (2007). Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology. Gynecol Oncol, 107(1), 106-112.
     
  463. Stepan H, Faber R (2007). Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol, 109(5), 1205-1206.
     
  464. Stepan H, Unversucht A, Wessel N, Faber R (2007). Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension, 49(4), 818-824.
     
  465. Horn LC, Meinel A, Handzel R, Einenkel J (2007). Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol, 11(4), 297-311.
     
  466. Horn LC, Hauptmann S, Leo C (2007). pRb, p16, and cyclin D1 in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol, 26(3), 269.
     
  467. Einenkel J, Steller W, Braumann UD, Horn LC, Krafft C (2007). Unrealistic expectations for IR microspectroscopic imaging. Nat Biotechnol, 25(1), 29-31.
     
  468. Höckel M, Dornhöfer N (2007). Neue Prinzipien und Techniken in der operativen Therapie der Zervixkarzinoms: Aktuelle systematische Übersicht Geburtsh Frauenheilk, 67(11), 1203-1216.
     
  469. Stepan H (2007). Translationale Forschung in der Geburtsmedizin: Beispiel angiogene Faktoren und Präeklampsie Geburtsh Frauenheilk, 67(8), 878-882.
     
  470. Briest S, Stearns V (2007). Chemotherapeutic Strategies for advanced breast cancer. Oncology (Williston Park), 21(11), 1325-1335.
     
  471. Briest S, Wolff AC (2007). Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer. Expert Rev Anticancer Ther, 7(9), 1243-1253.
     
  472. Rother K, Kirschner R, Sanger K, Bohlig L, Mossner J, Engeland K (2007). p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A. Oncogene, 26(13), 1949-1953.
     
  473. Muller GA, Heissig F, Engeland K (2007). Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences. Mol Biol Evol, 24(3), 814-826.
     
  474. Rother K, Li YY, Tschop K, Kirschner R, Muller GA, Mossner J, Engeland K (2007). Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73. Cell Cycle, 6(7), 853-862.
     
  475. Walther T, Stepan H (2007). Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders. Curr Hypertens Rep, 9(2), 128-132.
     
  476. Stepan H, Walther T (2007). Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension, 50(1), e3.
     
  477. Briest S, Davidson NE (2007). Aromatase inhibitors for breast cancer. Rev Endocr Metab Disord, 8(3), 215-228.
     
  478. Tschop K, Engeland K (2007). Cell cycle-dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements. FEBS J, 274(20), 5235-5249.
     
  479. Stepan H, Kramer T, Faber R (2007). Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab, 92(7), 2831-2834.
     
  480. Rother K, Dengl M, Lorenz J, Tschop K, Kirschner R, Mossner J, Engeland K (2007). Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73. FEBS Lett, 581(6), 1166-1172.
     
  481. Walther T, Tschope C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A, Nikolic A, Wang Y, Ebermann L, Siems WE, Bader M, Shakibaei M, Schultheiss HP, Dorner A (2007). Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation, 115(3), 333-344.
     
  482. Pankow K, Wang Y, Gembardt F, Krause E, Sun X, Krause G, Schultheiss HP, Siems WE, Walther T (2007). Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide. Circ Res, 101(9), 875-882.
     
  483. Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Reich O, Riethdorf L, Schmidt D (2007). [Pathoanatomical preparation and reporting for dysplasias and cancers of the cervix uteri: cervical biopsy, conization, radical hysterectomy and exenteration.] Pathologe, 28(4), 249-260.
     
  484. Kujat A, Veith VP, Faber R, Froster UG (2007). Prenatal diagnosis and genetic counseling in a case of spina bifida in a family with Waardenburg syndrome type I. Fetal Diagn Ther, 22(2), 155-158.
     
  485. Wentzensen N, Braumann UD, Einenkel J, Horn LC, von Knebel Doeberitz M, Loffler M, Kuska JP (2007). Combined serial section-based 3D reconstruction of cervical carcinoma invasion using H&E/p16INK4a/CD3 alternate staining. Cytometry A, 71(5), 327-333.
     
  486. Braumann UD, Scherf N, Einenkel J, Horn LC, Wentzensen N, Loeffler M, Kuska JP (2007). Large histological serial sections for computational tissue volume reconstruction. Methods Inf Med, 46(5), 614-622.
     
  487. Meyer A, Lehmann A, Schwarz R, Höckel M, Pilch H (2007). Psychoonkologische Betreuung von Brustkrebspatientinnen - erste Erfahrungen des zertifizierten universitären Brustzentrums Leipzig. Geburtsh Frauenheilk, 67(12), 1339-1344.
     
  488. Vaupel P, Hockel M, Mayer A (2007). Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal, 9(8), 1221-1235.
     
  489. Malberg H, Bauernschmitt R, Voss A, Walther T, Faber R, Stepan H, Wessel N (2007). Analysis of cardiovascular oscillations: a new approach to the early prediction of pre-eclampsia. Chaos, 17(1), 015113 ff.
     
  490. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol, 107(2), 310-315.
     
  491. Schmidt M, Bremer E, Hasenclever D, Victor A, Gehrmann M, Steiner E, Schiffer IB, Gebhardt S, Lehr HA, Mahlke M, Hermes M, Mustea A, Tanner B, Koelbl H, Pilch H, Hengstler JG (2007). Role of the progesterone receptor for paclitaxel resistance in primary breast cancer. Br J Cancer, 96(2), 241-247.
     
  492. Wang Y, de Waard MC, Sterner-Kock A, Stepan H, Schultheiss HP, Duncker DJ, Walther T (2007). Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail, 9(6-7/, 548-557.
     
  493. Kaufmann AM, Nieland JD, Jochmus I, Baur S, Friese K, Gabelsberger J, Gieseking F, Gissmann L, Glasschroder B, Grubert T, Hillemanns P, Hopfl R, Ikenberg H, Schwarz J, Karrasch M, Knoll A, Kuppers V, (2007). Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int J Cancer, 121(12), 2794-2800.
     
  494. Freddie CT, Ji Z, Marais A, Sharrocks AD (2007). Functional interactions between the Forkhead transcription factor FOXK1 and the MADS-box protein SRF. Nucleic Acids Res, 35(15), 5203-5212.
     
  495. Unversucht A, Einenkel J, Horn LC (2007). Intermittierende Unterbauchschmerzen bei zystischer Raumforderung im Becken Gynäkologe, 40(12), 1006-1008.
     
  496. Stepan H (2007). Intrauterine Wachstumsretardierung. In: Wacker J, Sillem M, Bastert G, Beckmann M, Therapiehandbuch Gynäkologie und Geburtshilfe. (S. 45-50), Heidelberg: Springer Verlag.
     
  497. Stepan H (2007). Dopplersonographie. In: Wacker J, Sillem M, Bastert G, Beckmann M, Therapiehandbuch Gynäkologie und Geburtshilfe. (S. 51-57), Heidelberg: Springer Verlag.
     


  498. 2006


  499. Horn LC, Richter CE, Hentschel B, Schutz A, Pilch H, Leo C, Hockel M (2006). Juxtatumoral desmoplastic stromal reaction is assiciated with high tumor cell dissociation in squamous cell carcinomas of the uterine cervix. Ann Diagn Pathol, 10(5), 253-256.
     
  500. Hockel M, Dornhofer N (2006). Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol, 7(10), 837-847.
     
  501. Einenkel J, Kuska JP, Horn LC, Wentzensen N, Hockel M, Braumann UD (2006). Combined three-dimensional microscopic visualisation of tumour-invasion front of cervical carcinoma. Lancet Oncol, 7(8), 698.
     
  502. Dornhofer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Hockel M, Le Q, Longaker M, Yang G, Koong A, Giaccia A (2006). Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res, 66(11), 5816-5827.
     
  503. Leo C, Horn LC, Rauscher C, Hentschel B, Liebmann A, Hildebrandt G, Hockel M (2006). Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis. Clin Cancer Res, 12(23), 6894-6900.
     
  504. Hockel M, Fritsch H (2006). Dissection bias in subperitoneal pelvic anatomy. Am J Obstet Gynecol, 194(5), 1504.
     
  505. Hockel M (2006). Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol, 32(8), 859-865.
     
  506. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B, Richter CE, Braumann UD, Einenkel J (2006). Pattern of invasion is of prognostic value in surgically treated cervical cancer patients. Gynecol Oncol, 103(3), 906-911.
     
  507. Vaupel P, Mayer A, Hockel M (2006). Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol, 182(2), 63-71.
     
  508. Einenkel J, Alexander H, Schotte D, Stumpp P, Horn LC (2006). Giant ovarian cysts: is a pre- and intraoperative drainage an advisable procedure? Int J Gynecol Cancer, 16(6), 2039-2043.
     
  509. Leo C, Horn LC, Hockel M (2006). Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer. Int J Gynecol Cancer, 16(3), 1314-1320.
     
  510. Horn LC, Lindner K, Szepankiewicz G, Edelmann J, Hentschel B, Tannapfel A, Bilek K, Liebert UG, Richter CE, Einenkel J, Leo C (2006). p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix. Int J Gynecol Pathol, 25(2), 182-186.
     
  511. Horn LC, Kowalzik J, Bilek K, Richter CE, Einenkel J (2006). Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. Eur J Obstet Gynecol Reprod Biol, 128(1-2), 10-14.
     
  512. Horn LC, Kowalzik J, Bilek K, Richter CE, Einenkel J (2006). Prognostic value of trophoblastic proliferation in complete hydatidiform moles in predicting persistent disease. Pathol Res Pract, 202(3), 151-156.
     
  513. Leo C, Faber S, Hentschel B, Hockel M, Horn LC (2006). The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Ann Diagn Pathol, 10(6), 327-332.
     
  514. Leo C, Briest S, Pilch H, Schutz A, Horn LC, Leinung S (2006). Granular cell tumor of the breast mimicking breast cancer. Eur J Obstet Gynecol Reprod Biol, 127(2), 268-270.
     
  515. Horn LC, Richter CE, Einenkel J, Tannapfel A, Liebert UG, Leo C (2006). p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium. Ann Diagn Pathol, 10(4), 193-196.
     
  516. Horn LC, Hentschel B, Bilek K, Richter CE, Einenkel J, Leo C (2006). Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol, 10(3), 140-143.
     
  517. Vaupel P, Mayer A, Hockel M (2006). Oxygenation status of primary and recurrent squamous cell carcinomas of the vulva. Eur J Gynaecol Oncol, 27(2), 142-146.
     
  518. Stepan H, Faber R (2006). Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med, 354(17), 1857-1858.
     
  519. Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T (2006). Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab, 91(6), 2424-2427.
     
  520. Walther T, Wessel N, Malberg H, Voss A, Stepan H, Faber R (2006). A combined technique for predicting pre-eclampsia: concurrent measurement of uterine perfusion and analysis of heart rate and blood pressure variability. J Hypertens, 24(4), 747-750.
     
  521. Voss A, Baumert M, Baier V, Stepan H, Walther T, Faber R (2006). Autonomic cardiovascular control in pregnancies with abnormal uterine perfusion. Am J Hypertens, 19(3), 306-312.
     
  522. Stepan H, Faber R, Dornhofer N, Huppertz B, Robitzki A, Walther T (2006). New insights into the biology of preeclampsia. Biol Reprod, 74(5), 772-776.
     
  523. Stepan H, Scheithauer S, Dornhofer N, Kramer T, Faber R (2006). Obesity as an obstetric risk factor: does it matter in a perinatal center? Obesity (Silver Spring), 14(5), 770-773.
     
  524. Stepan H, Nordmeyer AK, Faber R (2006). Proteinuria in hypertensive pregnancy diseases is associated with a longer persistence of hypertension postpartum. J Hum Hypertens, 20(2), 125-128.
     
  525. Höckel M (2006). Die totale mesometriale Resektion. Der Onkologe, 12(9), 901-907.
     
  526. Höckel M (2006). Die Post-Wertheim-Emanzipation- und Evolution der operativen Therapie des Zervixkarzinoms. Geburtshilfe und Frauenheilkunde, 66(8), 729-733.
     
  527. Vaupel P, Mayer A, Höckel M (2006). Einfluss des Hämoglobinspiegels auf die Tumoroxygenierung: "Je höher, desto besser" nicht mehr vertretbar. Info Onkologie, 9(1), 27-28.
     
  528. Alexander H (2006). Nachruf für Prof. Dr. med. habil. Karl-Wilhelm Haake Ärzteblatt Sachsen, 17(11), 574.
     
  529. Steller W, Einenkel J, Horn LC, Braumann UD, Binder H, Salzer R, Krafft C (2006). Delimitation of squamous cell cervical carcinoma using infrared microspectroscopic imaging. Anal Bioanal Chem, 384(1), 145-154.
     
  530. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440(7088), 1222-1226.
     
  531. Kaper F, Dornhoefer N, Giaccia AJ (2006). Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions. Cancer Res, 66(3), 1561-1569.
     
  532. Mayer A, Hockel M, Vaupel P (2006). Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking? Strahlenther Onkol, 182(9), 501-510.
     
  533. Raida M, Weiss T, Leo C, Lenz D, Tarnok A, Ameri K, Harris AL, Hockel M, Niederwieser D (2006). Circulating endothelial progenitor cells are inversely correlated with the median oxygen tension in the tumor tissue of patients with cervical cancer. Oncol Rep, 16(3), 597-601.
     
  534. Zehbe I, Schmidt M, Maeurer M, Leo C, Hockel M, Pilch H (2006). Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions. Zentralbl Gynakol, 128(5), 266-270.
     
  535. Baier V, Baumert M, Caminal P, Vallverdu M, Faber R, Voss A (2006). Hidden Markov models based on symbolic dynamics for statistical modeling of cardiovascular control in hypertensive pregnancy disorders. IEEE Trans Biomed Eng, 53(1), 140-143.
     
  536. Horn LC, Faber R, Stepan H, Simon E, Robel R, Wittekind C (2006). Umbilical cord hypercoiling and thinning: a rare cause of intrauterine death in the second trimester of pregnancy. Pediatr Dev Pathol, 9(1), 20-24.
     
  537. Kujat A, Veith VP, Faber R, Froster UG (2006). Prenatal Diagnosis and Genetic Counseling in a Case of Spina Bifida in a Family with Waardenburg Syndrome Type I. Fetal Diagn Ther, 22(2), 155-158.
     
  538. Masoudi H, Van Niekerk DJ, Gilks CB, Cheang M, Bilek K, Fischer U, Ehlen T, Miller D, Horn LC (2006). Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker. Histopathology, 49(5), 542-545.
     
  539. Scheid R, Voltz R, Briest S, Kluge R, von Cramon DY (2006). Clinical insights into paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry, 77(4), 529-530.
     
  540. Steller W, Einenkel J, Horn LC, Braumann UD, Binder H, Salzer R, Krafft C (2006). Delimitation of squamous cell cervical carcinoma using infrared microspectroscopic imaging. Anal Bioanal Chem, 384(1), 145-154.
     
  541. Braumann UD, Kuska JP, Einenkel J, Horn LC, Löffler M, Höckel M (2006). Tumour Invasion Pattern Analysis of Cervical Carcinoma in 3-D. In: SGSMP, SGSMP: Tagungsband Medizinische Physik (Gemeinsame Tagung Medizinische Physik 5.-6. Mai 2006 im Landeskrankenahus Feldkirch) (S. 10-15), Bern: Schweizerische Gesellschaft für Strahlenbiologie u.
     
  542. Stepan H, (2006). Mutter und Kind im Wochenbett. In: Kiechle M, Gynäkologie und Geburtshilfe. (S. 447-468), München: Urban & Fischer.
     


  543. 2005


  544. Horn LC, Faber S, Bilek K, Leo C (2005). Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium. J Cancer Res Clin Oncol, 131(4), 226-228.
     
  545. Leo C, Richter C, Horn LC, Schutz A, Pilch H, Hockel M (2005). Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia. Gynecol Oncol, 97(2), 602-606.
     
  546. Einenkel J, Stumpp P, Kosling S, Horn LC, Hockel M (2005). A misdiagnosed case of caesarean scar pregnancy. Arch Gynecol Obstet, 271(2), 178-181.
     
  547. Stepan H, Leo C, Purz S, Hockel M, Horn LC (2005). Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol, 122(2), 172-176.
     
  548. Höckel M, Dornhöfer N (2005). New developments in the surgical therapy of cervical carcinoma. J Turkish German Gynecol Assoc, 6(Supp. 1), 2-11.
     
  549. Hockel M, Horn LC, Fritsch H (2005). Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol, 6(10), 751-756.
     
  550. Höckel M (2005). Total mesometrial resection – Author's reply. Lancet Oncol, 6(12), 919-920.
     
  551. Hockel M, Dornhofer N (2005). The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection. Cancer Res, 65(8), 2997-3002.
     
  552. Braumann UD, Kuska JP, Einenkel J, Horn LC, Loffler M, Hockel M (2005). Three-dimensional reconstruction and quantification of cervical carcinoma invasion fronts from histological serial sections. IEEE Trans Med Imaging, 24(10), 1286-1307.
     
  553. Vaupel P, Mayer A, Briest S, Hockel M (2005). Hypoxia in breast cancer: Role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. Adv Exp Med Biol, 566, 333-342.
     
  554. Horn LC, Faber S, Einenkel J, Gilks CB, Richter CE, Stepan H, Purz S, Krumpe C, Leo C (2005). Der Einsatz von Tissue Microarrays (TMA) - eine neue Technik in der gynäkologischen Tumorforschung. Geburtsh Frauenheilk, 65(1), 23-29.
     
  555. Hockel M (2005). [New concepts for surgical therapy of cervical carcinoma] Pathologe, 26(4), 276-282.
     
  556. Höckel M, Dornhöfer N (2005). How to manage locally advanced primary and recurrent cancer of the uterine cervix: the surgeon's view. Rev Gynaecol Pract, 5(4), 212-220.
     
  557. Höckel M (2005). Neue Radikalität in der operativen Behandlung des Zervixkarzinoms. GYN Prakt Gynäkol, 10, 82-92.
     
  558. Höckel M, Grauel BM, Böhme M (2005). Therapiefortschritte beim primären Zervixkarzinom: Daten nicht belegt. Dt Ärzteblatt, 102(48), 3350-3351.
     
  559. Einenkel J, Braumann UD, Baier D, Kuska JP, Horn LC, Hockel M (2005). [Topographical anatomy of the female pelvis in ultrasound] Ultraschall Med, 26(5), 385-398.
     
  560. Horn LC, Kuhndel K, Pawlowitsch T, Leo C, Einenkel J (2005). Acquired lymphangioma circumscriptum of the vulva mimicking genital warts. Eur J Obstet Gynecol Reprod Biol, 123(1), 118-120.
     
  561. Horn LC, Braumann UD, Fischer U, Bilek K, Richter CE, Einenkel J (2005). Occult tumor cells in pelvic lymph nodes and parametrial tissue of small-sized FIGO IB1 squamous cell carcinomas of the uterine cervix--results of a pilot study. Pathol Res Pract, 201(7), 513-516.
     
  562. Horn LC, Dietel M, Einenkel J (2005). Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis. Eur J Obstet Gynecol Reprod Biol, 122(1), 4-12.
     
  563. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss HP, Faber R, Stepan H (2005). Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension, 46(6), 1275-1279.
     
  564. Stepan H, Faber R (2005). Urinary angiogenic factors in preeclampsia. Am J Obstet Gynecol, 193(6), 2181-2.
     
  565. Pfisterer C, Faber R, Horn LC (2005). Chorioamnionitis-induced changes of fetal extramedullar hematopoiesis in the second trimester of gestation. Is diagnosis from fetal autopsy possible? Virchows Arch, 446(2), 150-156.
     
  566. Walther T, Wessel N, Baumert M, Stepan H, Voss A, Faber R (2005). Longitudinal analysis of heart rate variability in chronic hypertensive pregnancy. Hypertens Res, 28(2), 113-118.
     
  567. Alexander H, Zmmermann G (2005). Ist endometriales hCG der Missing Link der Reproduktions-Medizin? Gynäkologische Nachrichten, 10(4), 1.
     
  568. Oerke S, Hohn H, Zehbe I, Pilch H, Schicketanz KH, Hitzler WE, Neukirch C, Freitag K, Maeurer MJ (2005). Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer. Int J Cancer, 114(5), 766-778.
     
  569. Schmidt M, Lewark B, Kohlschmidt N, Glawatz C, Steiner E, Tanner B, Pilch H, Weikel W, Kolbl H, Lehr HA (2005). Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing. Breast Cancer Res, 7(2), 256-266.
     
  570. Rothermel A, Kurz R, Ruffer M, Weigel W, Jahnke HG, Sedello AK, Stepan H, Faber R, Schulze-Forster K, Robitzki AA (2005). Cells on a chip--the use of electric properties for highly sensitive monitoring of blood-derived factors involved in angiotensin II type 1 receptor signalling. Cell Physiol Biochem, 16, 51-58.
     
  571. Horn LC, Raptis G, Fischer U, Hentschel B, Kohler U, Richter CE, Martin R (2005). CD44-v6 concentrations in carcinoma of the uterine cervix: lack of prognostic significance. Arch Gynecol Obstet, 273(2), 104-106.
     
  572. Chance B, Nioka S, Zhang J, Conant EF, Hwang E, Briest S, Orel SG, Schnall MD, Czerniecki BJ (2005). Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol, 12(8), 925-933.
     
  573. Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Riethdorf L, Schnurch HG, Schmidt D (2005). [Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies] Pathologe, 26(4), 266-272.
     
  574. Mayer A, Hockel M, Vaupel P (2005). Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clin Cancer Res, 11(20), 7220-7225.
     
  575. Mayer A, Hockel M, Wree A, Vaupel P (2005). Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers. Clin Cancer Res, 11(7), 2768-2773.
     
  576. Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, Sartor H, Horn LC, Hockel M, von Knebel Doeberitz M (2005). Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst, 97(24), 1816-1821.
     
  577. Watermann DO, Foldi M, Hanjalic-Beck A, Hasenburg A, Lughausen A, Prompeler H, Gitsch G, Stickeler E (2005). Three-dimensional ultrasound for the assessment of breast lesions. Ultrasound Obstet Gynecol, 25(6), 592-598.
     
  578. Kauffold J, Amer HA, Bergfeld U, Weber W, Sobiraj A (2005). The In Vitro Developmental Competence of Oocytes from Juvenile Calves is Related to Follicular Diameter. J Reprod Dev, 51(3), 325-332.
     
  579. Kauffold J, Amer HA, Bergfeld U, Müller F, Weber W, Sobiraj A (2005). Offspring from Non-stimulated Calves at the Age Younger than Two Months - A Preliminary Report. J Reprod Dev, 51(4), 527-532.
     
  580. Zosel J, Gerlach F, Kaden H, Weber W, Alexander H (2005). Telemetrisches Messsystem für das Monitoring der Basaltemperatur im Reproduktionsscreening der Frau. Dresdner Beiträge zur Sensorik, 20, 265-268.
     
  581. Kujat A, Faber R, Froster UG (2005). Klinik und Diagnostik des Waardenburg-Syndroms Typ 1. pädiatrie hautnah, 3, 148-150.
     
  582. Höckel M, Schlenger K, Höckel S, Vaupel P, (2005). Tümör hipoksisi ile malign progresyon arasindaki illski: Serviks kanserinde klinik kanitlar. In: Vaupel P, Kelleher KD, Tümör Hipoksisi. (S. 65-74), Istanbul: Yüce.
     
  583. Vaupel P, Höckel M (2005). Meme kanserinde oksijelenme düzeyl: Mainz deneyimi. In: Vaupel P, Kelleher KD, Tümör Hipoksisi (S. 1-12), Istanbul: Yüce.
     


  584. 2004


  585. Hockel M, Dornhofer N (2004). Anatomical reconstruction after vulvectomy. Obstet Gynecol, 103(5), 1125-1128.
     
  586. Vaupel P, Mayer A, Hockel M (2004). Tumor hypoxia and malignant progression. Methods Enzymol, 381, 335-354.
     
  587. Leo C, Giaccia AJ, Denko NC (2004). The hypoxic tumor microenvironment and gene expression. Semin Radiat Oncol, 14(3), 207-214.
     
  588. Horn LC, Schnurrbusch U, Bilek K, Hentschel B, Einenkel J (2004). Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer, 14(2), 348-353.
     
  589. Braumann UD, Kuska JP, Einenkel J, Horn LC and Höckel M (2004). 3D-Reconstruction and quantification of tumour invasion for squamous cell carcinoma of the uterine cervix. Biomed Tech (Berl), 49(Suppl 2/1), 206-207.
     
  590. Höckel M (2004). Nervenschonende operative Therapie des Zervixkarzinoms. Gynäkologe, 37, 893-900.
     
  591. Walther T, Stepan H (2004). C-type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol, 180(1), 17-22.
     
  592. Stepan H, Faber R, Froster UG, Heinritz W, Wallaschofski H, Dechend R, Walther T, Huppertz B (2004). Pre-eclampsia as a 'three stage problem'--a workshop report. Placenta, 25(6), 585-587.
     
  593. Stepan H, Heihoff-Klose A, Faber R (2004). Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion. Ultrasound Obstet Gynecol, 23(6), 579-583.
     
  594. Faber R, Stepan H (2004). Umbilical cord entanglement in monoamniotic twins. Ultrasound Obstet Gynecol, 24(5), 592-593.
     
  595. Froster UG, Heinritz W, Bennek J, Horn LC, Faber R (2004). Another case of autosomal dominant exstrophy of the bladder. Prenat Diagn, 24(5), 375-377.
     
  596. Strenge S, Froster UG, Wanders RJ, Gartner J, Maier EM, Muntau AC, Faber R (2004). First-trimester increased nuchal translucency as a prenatal sign of Zellweger syndrome. Prenat Diagn, 24(2), 151-153.
     
  597. Faber R, Stepan H, Baumert M, Voss A, Walther T (2004). Analysis of blood pressure waveform: a new method for the classification of hypertensive pregnancy disorders. J Hum Hypertens, 18(2), 135-137.
     
  598. Faber R, Baumert M, Stepan H, Wessel N, Voss A, Walther T (2004). Baroreflex sensitivity, heart rate, and blood pressure variability in hypertensive pregnancy disorders. J Hum Hypertens, 18(10), 707-712.
     
  599. Horn LC, Langner A, Stiehl P, Wittekind C, Faber R (2004). Identification of the causes of intrauterine death during 310 consecutive autopsies. Eur J Obstet Gynecol Reprod Biol, 113(2), 134-138.
     
  600. Faber R, Stepan H, Baumert M, Voss A, Walther T (2004). Changes of blood pressure and heart rate variability precede a grand mal seizure in a pregnant woman. J Perinat Med, 32(6), 538-540.
     
  601. Glasow S, Stepan H, Sack U, Faber R (2004). Cervical immunoglobulin A and altered vaginal flora in pregnant women with threatened preterm delivery. J Perinat Med, 32(1), 37-41.
     
  602. Stepan H, Faber R (2004). [Abnormal uterine perfusion in the second trimester - current pathophysiological, diagnostic and therapeutic aspects.] Z Geburtshilfe Neonatol, 208(6), 205-209.
     
  603. Stepan H, Geide A, Faber R (2004). Soluble fms-like tyrosine kinase 1. N Engl J Med, 351(21), 2241-2242.
     
  604. Briest S, Pawelka MK, Leinung S, Horn LC (2004). Die Sentinel-Lymphknoten-Biopsie beim Mammakarzinom Konzept und Management Ärzteblatt Sachsen, 15(10), 480-483.
     
  605. Braumann UD, Kuska JP, Einenkel J, Horn LC, Höckel M (2004). How to Quantify Cervical Carcinoma Invasion Fronts in 3D? Bulletin 1/2004 of the Swiss Society of Radiobiology and Medical Physics, 53, 9-11.
     
  606. Alexander H (2004). Prof. Dr. med. habil. Karl-Wilhelm Haake zum 70. Geburtstag Ärzteblatt Sachsen, 15(5), 200.
     
  607. Mayer A, Wree A, Hockel M, Leo C, Pilch H, Vaupel P (2004). Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res, 64(16), 5876-5881.
     
  608. Horn LC, Schutz A, Heinemann K, Einenkel J, Schneider JP (2004). Multicystic peritoneal mesothelioma of the omentum. Eur J Obstet Gynecol Reprod Biol, 116(2), 246-247.
     
  609. Walther T, Stepan H, Pankow K, Becker M, Schultheiss HP, Siems WE (2004). Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide. Biol Chem, 385(2), 179-184.
     
  610. Walther T, Stepan H, Pankow K, Gembardt F, Faber R, Schultheiss HP, Siems WE (2004). Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus. BJOG, 111(5), 452-455.
     
  611. Wallaschofski H, Kobsar A, Sokolova O, Siegemund A, Stepan H, Faber R, Eigenthaler M, Lohmann T (2004). Differences in platelet activation by prolactin and leptin. Horm Metab Res, 36(7), 453-457.
     
  612. Wallenborn J, Rohrbach A, Stepan H, Kühnert I, Olthoff D (2004). Das peripartale Lungenödem - Anästhesiologische Aspekte eines geburtshilflichen Notfalls Anästh Intensivmed, 45(6), 341-350.
     
  613. Strenge S, Heinritz W, Faber R, Froster UG (2004). FFTS - diskordante Anomalien bei monozygoten Zwillingen pädiatrie hautnah, 8, 451-453.
     
  614. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, Liebert UG (2004). PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol, 30(4), 302-308.
     
  615. Höckel M (2004). Pelvic side wall recurrences of cervical cancer: The LEER/CORT procedures. In: Smith, JR, Del Priore G, Curtin J, Monaghan J, An Atlas of Gynecological Oncology 2nd edition. (S. ), London: Martin Dunitz.
     
  616. Vaupel P, Höckel M (2004). Durchblutung, Oxygenierungsstatus und metabolisches Mikromilieu des Mammakarzinoms. In: Untch M, Sittek H, Bauerfeind I, Reiser M, Hepp H, Diagnostik und Therapie des Mammakarzinoms - State of the Art. (S. 347-367), München: W. Zuckschwerdt.
     
  617. Braumann UD, Kuska JP, Einenkel J, Horn LC, Höckel M (2004). Quantification of Tumour Invasion Fronts using 3D Reconstructed Histological Serial Sections. In: Tolxdorff T, Braun J, Handels H, Horsch A, Bildverarbeitung für die Medizin 2004 - Algorithmen, Systeme, Anwendungen. Proceedings des Workshops vom 29. - 30. März 2004 in Berlin (S. 70-74), Heidelberg: Springer-Verlag.
     
  618. Braumann UD, Kuska JP, Einenkel J, Horn LC, Höckel M (2004). 3D-Rekonstruktion und - Quantifizierung der Tumorinvasion beim Zervixkarzinom anhand histologischer Serienschnitte. In: Wolf U, Wilke W, Medizinische Physik (S. 264-265), Köln: Deutsche Gesellschaft für Medizinische Physik.